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ABSTRACT 
The production of FBj by Fusarium proliferatum M-5991 was enhanced from 300 to 
1400 |imoIes/L by the addition of 0.75% com hull extract (CHE) to modified Myro liquid 
medium (LM). Three continuous batch fermentations of F. proliferatum M-5991 in 10. 12. 
and 12 L modified Myro LM produced 28 mmoles of FB, which were purified to >95% by a 
combination of XAD-16, Cg, DEAE-Sepharose, and C,g chromatography. At day 12 of 
culture, ['^C]-acetate was incorporated into 29 fimoles of FB, in 50 ml modified Myro LM 
containing F. proliferatum which produced, after purification, 24 [imoles ['•'C]-FB, at 95% 
purity with a specific activity of 1.7 mCi/mmole. In a urinary excretion study, 9 male and 9 
female Fisher F344/N rats were gavaged wdth 0.69 fimoles of ['''CJ-FB, or ['^C]-hydrolyzed 
FB, ([''C]-HFB,) or ["C]-FB,-FRU (["C]-FB,-FRU)/kg body weight (BW). The urinary 
excretion by male and female rats was 12.8 and 17.3% of the ['^C]-HFB, dose, 4.2 and 4.6% 
of the ['""Cl-FBi-FRU dose, and 0.4 and 0.7% of the ['"'CJ-FB, dose, respectively. In a biliary 
excretion study, 9 Sprague-Dawley female rats were dosed by gavage with 0.69 f^mole ['"*€]-
FB, or ['"Q-HFB, or ['^C]-FB|-FRU/kg BW. There was no difference in the biliary 
excretion of the 3 FB compounds by these rats with 1.4% of the dose being excreted in the 
bile 4-h after dosing. These results, that HFB, was absorbed to a greater extent by rats than 
FB,, complement previous reports that FB, toxicity was > HFB, toxicity in cell cultures and 
as toxic on a dietary basis in rats. Because dietary FB,-FRU was absorbed to a greater extent 
than FB„ absorption differences between the two compounds do not explain the lack of 
toxicity of FB,-FRU in rats. 
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CHAPTER 1. GENERAL INTRODUCTION 
A. Introduction 
The purpose of this dissertation is to describe the production, purification, and 
radiolabeling of fumonisin B, (FB,), and evaluate the urinary and biliary excretion of ['•*€]-
FB|, ['•'CJ-hydrolyzed FB, (HFB,), and ["'CJ-FB,-Fructose (FRU) by rats. The urinary and 
biliary excretion of these compounds were studied to gain insight into their bioavailability in 
animals. 
Fusarium moniliforme and Fusariumproliferatum have been shown to produce FB, 
and other FBs, along with other mycotoxins, in field com or in defined mediums such as 
solid com medium (SCM), solid rice medium (SRM), or liquid medium (LM) (Gelderblom et 
al., 1988; Cawood et al., 1991). These fungal pathogens invade maize plants by many 
pathways including insect damaged kernels and may result in maize diseases such as stalk 
and ear rot and kemel infection (Ross et al., 1991; Nelson, 1992). 
B. Dissertation Organization 
This dissertation is organized into 6 chapters. Chapter 1 is a general introduction; 
Chapter 2 is a literature review; Chapters 3 and 4 are published work on the production and 
purification of FB, (Dantzer et al., 1996a and 1996b); and Chapter 5 is a manuscript to be 
submitted for publication on the bioavailability of 0.69 [amoles of ['"CJ-FB, or ['^C]-HFB, or 
['•'C]-FB,-FRU/kg BW, as determined by urinary and biliary excretion, by rats. All figures 
and tables are renumerated for each Chapter or Appendix. 
-) 
Because Chapters 3 and 4 are already published, there were some inconsistencies with 
abbreviations which were later found to be more appropriate. Following is a list of 
abbreviations and the chapters in which they are referenced. [Solid com medium (SCM)-
Chapter 2], [com culture material (CCM)-Chapters 3 and 4]; [modified Myro liquid medium 
(modified Myro LM)-Chapters 2 and 5], [modified Myro medium (MM medium)-Chapters 3 
and 4]; [fimole FB/L-Chapters 2, 5, and 6], [mg FB/L-Chapters 3 and 4]; [ml-Chapters 2 and 
5], [mL-Chapters 3 and 4]. 
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CHAPTER 2. LITERATURE REVIEW 
A. Why Study Fumonisins? 
The fumonisin B series (FBs) refer to a group of mycotoxins (FB,. FB,. FB,, and FB4) 
that have a common 12,16-dimethyI-14,15-diesterpropane-l,2,3-tricarboxyiate-
hydroxyicosane structure (Fig. 1) and are produced mainly by Fusarium moniliforme and 
Fusarium proliferatum (Gelderblom et al., 1988; Cawood et al., 1991, Wilkes et al.. 1995; 
Beier et al., 1995). The FBs are known to cause different diseases in horses, pigs, or rats 
(Marasas et al, 1984). Fumonisin B, has been associated epidemiologically with human 
esophageal cancer (Sydenham et al., 1990; Rheeder et al., 1992; Chu and Li, 1994.). The 
ftmionisin A series (FAs) and the ftmionisin P series (FPs), also produced by F. moniliforme 
and F. proliferatum, are N-acetyl- and N-3-hydroxypyridinium-FB mycotoxins, respectively 
(Fig. 1) (Musser and Plattner, 1997). 
Cultures of F. moniliforme Medical Research Council (MRC) in Tygerberg South 
Africa have been shown to produce FBs (Gelderblom et al., 1988; Gelderblom et al., 1991; 
Norred et al., 1992; Voss et al., 1993). Kriek et al. (1981) reported that F. moniliforme 
MRC-826 grown in solid com medium (SCM) induced toxicities when fed to horses, pigs, 
sheep, rats, and baboons. Marasas et al. (1984) reported an induction of hepatic lesions and 
mortality in rats fed F. moniliforme MRC-826 grown in SCM. Jaskiewicz et al. (1987) 
reported an induction of liver cancer in rats fed F. moniliforme MRC-826 grown in SCM. 
However, these SCM may have contained many mycotoxins. 
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Equine leucoencephalomalacia (ELEM) is a brain disease which has been associated 
with the consumption of FB-contaminated com. Symptoms were induced in horses fed 14 
l^moles of purified FB,/kg diet (Marasas et al, 1988). Symptoms of ELEM included 
deterioration and liquefaction of the white-gray matter in the brain of a horse resulting in 
ataxia, clumsiness, stupor, and death (Kellerman at al., 1991). Porcine pulmonary edema 
(PPE) is a lung disease that has been associated with the consumption of FB-contaminated 
com. Symptoms were induced in swine fed 35 ^moles of purified FB|/kg diet (Harrison et 
al., 1990). Symptoms of PPE include leakage of serum through the lungs, filling the thoracic 
cavities, and death. The FBs are not toxic to cattle (Osweiler et al., 1993; Smith and Thakur, 
1996) nor have they previously been reported in the milk of lactating cows fed com 
containing FBs (Richard et al., 1996). Laboratory rats developed liver cancer and kidney 
toxicity when fed 69 ^imoles of purified FBs (Gelderblom et al., 1991; Voss et al., 1993). 
The cancer causing ability of FB, is thought to be primarily due to its accumulatory effects 
on sphingoid bases (Schroeder et al., 1994). The FBs resemble sphinganine and sphingosine 
and inhibit ceramide synthase, one of the enzymes involved in the conversion of sphinganine 
to sphingosine (Merrill et al., 1993). Mechanisms of FB toxicities may include interfering 
with sphingolipid synthesis, inhibition of Na/K ATPase, inhibition of protein kinase C 
(PKC), release of intracellular Ca"", promotion of RB dephosphorylation, and induction of 
apoptosis (Merrill et al., 1996). Mechanisms of FB carcinogenicities may include activation 
of epidermal growth factors (EGF) receptor/MAP kinase, activation of phospholipase D 
and/or inhibition of phosphatidic acid phosphohydrolase, release of intracellular Ca**, 
activation of AP-1, cytotoxicity for normal cells, loss of regulation of differentiation, loss of 
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regulation of apoptosis, and loss of lipid mediators of tumor necrosis factors caused by 
sphingolipid disruption (Merrill et al., 1996). 
The FBs are produced by fungi associated with com. However, com destined for 
animal foods has higher populations of these fungi suggesting a higher risk of FB 
contamination in such com than in com meant for human foods (Ross et al.. 1991). 
Fumonisins have been detected in com products destined for humans (Hopmans and Murphy, 
1993; Pohland, 1996; Bullerman, 1996). The effects on humans of consumption of FBs are 
not known. High incidences of esophageal cancer in humans have been associated with the 
consumption of FB containing com (Chu and Li, 1994). 
Because FBs have the ability to cause diseases in animals and their effects on humans 
are uncertain, it is necessary to take precautions to minimize the occurrence of FBs in foods. 
Measuring the bioavailability of FBs in laboratory animals can help us to understand the 
toxicokinetics of FBs and aid in establishing safe levels of FBs that may be consumed by 
animals and humans. 
Processing of foods containing FB, can produce hydrolyzed FB, (HFB,) in which the 
tricarboxylic acid (TCA) groups are removed from the FB, backbone (Fig. 1). 
Nixtamalization, the process for making tortilla flour or masa in which com is subjected to 
alkaline heating and steeping, can form HFB, (Hendrich et al.. 1993; Murphy et al., 1996). 
Another form of FB,, FB,-fructose (FB,-FRU) was formed when FB, was heated in the 
presence of a reducing sugar at pH > 7 (Fig. 1). The amine group on FB, can condense with 
the carboxyl group on a reducing sugar such as glucose, fhictose, or lactose, blocking the 
amine group and making the FB, molecule undetectable by using conventional derivatization 
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detection means. These modifications to FBi may alter its detection, bioavailability, and/or 
toxicity (Bordson et al., 1995; Jackson et ai, 1996a; Jackson et al., 1996b; Murphy et ai, 
1996). For the assurance of a safe human and animal food supply, all forms of FBs that may 
be found in food products must be evaluated for their bioavailability, safety, and toxicity in 
animals. 
NHR, OR 
ORi R3 OH 
FUMONISIN Rt R2 R3 R4 
Bi TCA OH OH H 
B2 TCA H OH H 
B3 TCA OH H H 
B4 TCA H H H 
HFBi H OH OH H 
FBi-FRU* TCA OH OH FRUCTOSE 
Ai TCA OH OH COCH3 
A2 TCA H OH COCH3 
Pi TCA OH OH 3HP 
P2 TCA H OH 3HP 
Figure 1. Chemical structures of the major mycotoxins produced by Fusarium moniliforme 
and Fusarium proliferatum: fumonisin B series (FBi, FB2, FB3, and FB4), hydrolyzed 
fumonisin Bi (HFBi), fumonisin Bi-fhictose conjugate (FBi-FRU) (*may be formed during 
food processing), fumonisin A series (FAi, FA2), and fumonisin P series (FPi and FP2). TCA 
= propane-1,2,3-tricarboxylic acid group [C0CH2CH(C02H)CH2C02H]. 3HP = 3-
Hydroxypyridinium [NC5H5O]. 
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B. Fumonisins in Corn 
1. Fusarium strains and toxins 
The fungal species F. moniliforme Sheldon and F. proliferatum (Matsushima) 
Nirenberg are in the Liseola section of the genus Fusarium. These species do not form 
chlamydospores, contain unbranched and branched monophialide and/or polyphialide 
macroconidiophores, and are distinguished by morphology, mode of microconidia formation, 
and microconidiophore morphology (Nelson et al., 1983; Nelson, 1992). The reproductive 
state (perfect state) oiF. moniliforme is called Gibberella fujikuroi (Sawada) Wollenw and 
has been known to produce mycotoxins including deoxynivalenol, diacetoxyscirpenol. 
fiisaric acid, fusarins, gibberellins, moniliformin, T-2 toxin, zearalenone, and the fumonisins 
(Marasas et al., 1984; Nelson, 1992). Different fungal species normally are not classified as 
having the same perfect state. However, the perfect state of F. proliferatum is also 
Gibberella Jujikuroi (Leslie, 1996). Mycotoxins produced by F. proliferatum include fusaric 
acid, gibberellin, moniliformin, the fimionisins, beauvericin, and fusaproliferin (Marasas et 
ai, 1984; Nelson and Juba, 1994; Plattoer and Nelson 1994; Ritieni, et al., 1995). Some 
strains of F. moniliforme consistently produced FB, as their major FB constituent but other 
strains of F. proliferatum did not (Nelson et al., 1994). Fusarium proliferatum strains from 
the Fusarium Research Center Collection (University Park, PA) found to produce FBs (in 
order of highest to lowest) were M-5991 and M-6293 for FB, production; M-6104, M-6293. 
and M-5991 for FB, production; and M-6284, M-6290, and M-6293 for FB, production. The 
mycotoxin produced by Alternaria alternata f sp. lycopersici, AAL-toxin, is structurally 
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similar to FBs and may be produced by the same biosynthetic mechanisms that F. 
moniliforme used to produce FBs (Gilchrist et al., 1992). 
An alternate method for classification based on mating populations within G. 
fujikuroi has been reported by Leslie et al. (1992). Gibberella fujikuroi has 6 different 
mating populations, A through F, all within Fusarium section Liseola. Of 25 unique strains 
of F. moniliforme isolated from com kemels associated with ELEM, all were mating 
population 'A' and produced FB, (Leslie et al., 1992). However. FB, production by F. 
moniliforme was not required for pathogenicity on maize seedlings (Desjardins et al., 1995). 
The 'D' mating population of section Liseola is comprised of F. proliferatum and produces 
FBs. Other Fusarium species have been reported to produced FBs such as F. subglutinans 
which is in the 'B' mating population (Leslie et al., 1996). 
The Fusarium fungi are natural soil contaminants and exist worldwide. They are 
responsible for causing many com diseases. The FB,-producing fimgus reported most 
frequently from shelled com from the United States of America (USA) is F. moniliforme 
(Kommedahl and Windels, 1981). This fungus causes ear rot, seedling blight, root rot. stalk 
rot, and storage decay in maize. Tseng et al. (1995) cultured F. moniliforme strains from 
Taiwan on com, sorghum, rice, and sugarcane, resulting in the production of FB, and FBi. 
In summary, F. moniliforme and F. proliferatum are wide-spread in soil and produce 
FBs, along with other mycotoxins, on a major food staple: com. 
2. Occurrence of Fusarium fungi and FBs in foods 
Strains of F. moniliforme have been isolated from various human food commodities 
including com, asparagus, watermelon, and vanilla (Bars et al., 1994). Gilchrist et al. (1992) 
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isolated F. moniliforme from ripe tomato fruits with symptoms of tomato black mold and 
from ears of com with symptoms of pink ear rot. Fumonisin-producing strains of F. 
moniliforme are present in many food commodities, such as com, destined for human 
consumption. Bullerman and Tsai (1994) isolated Fusarium fungi from the USA during 
1991 and 1992 in yellow and white dent com, popcorn, and sweet com. The percentages of 
infected kernels from the dent com and popcorn ranged from 8.4-36.2% and 1.8-10.3%. 
respectively. Fresh cob sweet com were infected by Fusarium frmgi to a lesser extent with a 
mean percentage of kernel infection of 0.3%, whereas frozen sweet com kernels had a mean 
percentage of infected kemels of 8.0%. Bullerman and Tsai (1994) reported that the germ 
and bran of milled dent com had the highest Fusarium infection and the flaking grit was the 
lowest, suggesting that the fimgi may concentrate in the germ area and just under the 
pericarp. They suggested that the low levels of Fusarium contamination in flaking grit 
confirmed the findings by Stack and Eppley (1992) that flake cereal has not been associated 
with high levels of FBs. Good quality com kemels meant for human consumption contained 
low levels of FBs while other com material such as damaged com, cob parts, stalk parts and 
screenings contained 74-770 fimoles of FBs/kg solids (Bullerman and Tsai, 1994). Strains of 
F. moniliforme were isolated from com or sorghum from Indonesia, Philippines, and 
Thailand. The F. moniliforme cultures produced up to 203 [imoles of FB, and 62 lamoles of 
FBj/L of LM (Miller et al., 1993). Visconti and Doko (1994) cultured F. moniliforme strains 
isolated from com, sorghum, wheat, barley, and mixed feed in Italy, Spain, Poland, and 
France on SCM and produced up to 5.7 mmoles of FB,/kg SCM. The isolates from com 
produced the highest amoimts of FB, followed by isolates from wheat, barley, and sorghum. 
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These data suggested that Europe and the USA had a similar pattern of FB-producing 
Fusarium stains from different substrates. 
Murphy et al. (1993) reported that com screenings had ID-fold greater amounts of 
FBs than intact com isolated from Iowa, Wisconsin, and Illinois during 1988 to 1990. The 
highest levels of FB, were found in com from the 1989 crop year which contained 53 famoles 
FB,/kg solids. Levels of FB, were 50-fold less than FB„ while levels of FB, were 190-fold 
less than FB, in the com samples from the 1989 crop year but both were linearly correlated 
with FB, concentration. Thiel et al. (1992) found 0-3.9 lamoles FB, and 0-1.5 jimoles FB-,/kg 
solids of commercial com products meant for human consumption in the USA. Tmcksess et 
al. (1995) analyzed USA commercial canned and frozen sweet com samples for FB,. Out of 
97 samples, 35 contained up to 0.1 ^moles of FB,/kg com wet weight (wt). One caimed com 
and one frozen com sample contained 0.3 and 0.5 [amoles of FB,/kg com wet wt, 
respectively. Hopmans et al. (1993) reported 23 to 117 i^moles FB,/kg of human com 
containing foods. In comparison of white and yellow commeal, canned yellow com, tortilla 
chips, and masa, the highest levels of FB, were found in yellow com meal. 
Rheeder et al. (1994) found South African com being shipped to Taiwan in 1989 to 
contain up to 1.2 lamoles FB,/kg solids. Other mycotoxins found included FB, and 
moniliformin at less than half the concentration of FB,. Ueno et al. (1993) found FB, and 
FB, present in com kemels, gluten feeds, com grits, and com-based products in Asian 
countries during 1988-1992. The highest levels of these mycotoxins were found in com 
kemels imported from the USA in 1988 which contained up to 5.7 and 14.4 fimoles of FB, 
and FB,/kg solids, respectively. Two out of 7 of the FB, containing USA kemel samples also 
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contained aflatoxin B,. The coexistence of FBs and aflatoxin is of particular concern because 
FB| is a promoter and aflatoxin is an initiator of cancer (Gelderblom et al.. 1988; Ellis et al.. 
1991). Chu and Li (1994) found 49 mmoles of FB,/kg solids from com samples collected 
from households of counties of Cixian and Linxian of the People's Republic of China. There 
was no visible mold contamination on the com samples. Other commodities have been 
shown to contain low levels of FBs including beer, Italian com grits, USA blue com meal, 
and self rising white meal (Scott and Lawrence, 1995; Shephard et al., 1996). 
Companion animal foods have also been reported to contain FBs. Hopmans et al. 
(1993) reported 303 to 1956 |j.moles FB,/kg pet food. The highest levels of FB, were found 
in dog food. Shephard et al. (1996) reported 458 |4.moles of FB|/kg swine feed and up to 100 
[imoles of FB,/kg horse feed. 
The FBs are in most com products to some extent. This is important because the 
potential exists that relatively high levels of FBs could exist in human or animal foods. 
3. Detoxification of FBs 
Detoxification of aflatoxin-contaminated com can be achieved by treating the com 
material with ammonia (Brekke et al, 1977). However, detoxification of aflatoxin by 
ammoniation is not approved for interstate commerce by the FDA. Norred e/ a/ (1991) 
incubated SCM which contained FB, produced by F. moniliforme MRC-826 with ammonium 
hydroxide at 50°C for 4 d which reduced the FB, content in the SCM by 50%, but the toxicity 
to rats was not reduced nor was HFB, measured (Norred et al., 1991). Neither increasing the 
concentration of ammonia to 5% nor decreasing the duration of the ammonia treatment from 
4 to 1 d affected the final concentration of FB,. The detectable FB, levels increased 5-fold 
within 4 d following the ammoniation treatment, which suggested that the FB, may have 
been reversibly bound to the SCM matrix. Park et al. (1992) treated FB,-containing SCM 
with ammonia resulting in 79% reduction in the FB, content without production of mutagenic 
compounds. The SCM was found to contain 120 |.imoles FB,/kg SCM before being exposed 
to 2% ammonia for 60 min at 15% moisture, 60 pounds per square inch (psi), and 20''C and at 
13% moisture, 17 psi, and 125°C. However, the proposed detoxification of FB, was not 
confirmed by feeding laboratory animals nor was the SCM analyzed for HFB,. Voss et al. 
(1992) found that FB, was reduced but not detoxified in ammoniated SCM. The SCM was 
cultured with F. moniliforme MRC 826 and contained 140 [imoles FB,/kg SCM. After 
treating with 2% ammonia at 50°C for >1 d and dried, the SCM was found to contain 29% 
less FB,. The ammoniated and non-ammoniated SCM increased serum ALT, AST, AP. and 
GGT activities when fed to rats. Ammonia treatment of FB, in SCM was not an effective 
method for its detoxification. 
Nixtamilization is the process for masa and tortilla flour production involving alkaline 
cooking and steeping. This process converts FB, to HFB, (Hendrich et al., 1993). Hendrich 
et al. (1993) mixed FB-containing com kernels with clean com to contain 69 |imoles of 
FB,/kg of com. The FB, was produced by F. proliferatum M-5991 in SCM. The com 
kemels were nixtamilized by heating with 1.2% Ca(0H)2 at 80-100°C for 60 min, steeped 
overnight, and washed. The nixtamilized com was as hepatocarcinogenic as the non-
nixtamilized com in diethylnitrosamine (DEN) initiated male Fisher rats fed nutritionally 
adequate diets. However, nutritionally inadequate diets containing nixtamilized com 
produced fewer adenomas than non-nixtamilized com in rats. 
Dupuy et al. (1993) and Bars et al. (1994) found SCM containing FB, to be relatively 
resistant to drying of com. The t,;, of 2.1 mmoles FB, in SCM were 10, 38. 175, and 480 min 
when heated at 150, 125, 100, and 75°C, respectively. The FB, was produced by F. 
moniliforme in SCM. However, these SCMs were not analyzed for amine blocked-FB, or for 
toxicity. Due to the high required temperature and long heat exposure time, thermal 
treatment may not be practical for detoxification of FB, in SCM. Bordson et al. (1995) 
added 10 ml of HjO to 10 g of com samples containing 22 |j.moles of FB, and 6.2 jimoles of 
FBi at 110°C for 24-h resulting in a 93% reduction in detectable FB, and a 66% reduction in 
FBi. Similarly dried pelleted mixed feed samples resulted in undetectable FB, and a 44% 
reduction in FB,. However, these samples were not analyzed for toxicity or for the presence 
of amine blocked-FB,. By heating FB, and FB, in a pH 4 buffered solution at I50°C for 60 
min, Jackson et al. (1996a and 1996b) reduced the levels of FB, by 90% and the levels of FB, 
by 70%. However, HFB„ HFB,, partially HFB,, (PHFB,), and PHFE, were formed. The 
decomposition rate of FB, was pH dependent with a greater rate at pH 4 than pH 7 or 10. At 
pH 7 and 10, FB, was reduced by 20 and 50%, respectively. 
The nonenzymatic browning reaction may block the amine group of FB by forming a 
Schiffs base with a reducing sugar. Murphy et al. (1995) incubated 69.3 (amoles of FB, with 
100 mM fructose or glucose and 50 mM potassium phosphate, pH 7.0, at 80°C for 48-h 
which resulted in a 90% decrease in the detectability of FB,. Lu et al. (1997) reported FB,-
FRU did not induce liver cancer in DEN initiated rats suggesting that FB, was detoxified. 
The FBs have not been shown to be metabolized by enzymes. Murphy et al. (1996) 
incubated FB, with monoamine oxidase, diamine oxidase, L-amino acid oxidase, and D-
amino acid oxidase without changing the detectability of FB, by OPA-derivatization. 
Cawood et al. (1994) incubated FB, with microsomal enzyme preparations without the 
formation of FB metabolites suggesting that FB, was not metabolized by the esterases or by 
the cytochrome P-450 monooxygenase enzymes. 
The FBs are relatively stable to the temperatures and treatments associated with 
foods. However, TCA groups can be hydrolyzed or the amine group blocked on the FB 
backbone potentially resulting in the formation of other toxic or non-toxic compounds. 
C. Growth Parameters of Fusarium Fungi 
1. Solid growth media 
Fusarium moniliforme and F. proliferatum produce FBs when cultured on solid com 
or rice media. Gilchrist et al. (1992) inoculated 1.5 ml HjO/g SCM or solid rice medium 
(SRM) with F. moniliforme which produced 4.2 mmoles FBs/kg dry wt (DW) of SCM and 
6.7 mmoles of FBs/kg DW of SRM. Desjardins et al. (1994) inoculated 50 g of com and 11 
ml HjO with F. moniliforme which produced 8.0 mmoles FB, and 4.4 mmoles FBj/kg DW of 
SCM. Nelson et al. (1994) inoculated 500 g com and 500 ml dHiO with F. proliferatum M-
5991 which produced 8.0 mmoles FB,/kg DW of SCM. Optimal moisture content of the 
SCM for FB, production by F. moniliforme was found to be 32% (Bars et al., 1994). These 
data suggested that F. moniliforme or F. proliferatum may produce up to 8.0 mmoles FB,/kg 
DW of SCM or 6.7 mmoles FB,/kg DW of SRM. 
Fungal mutations has been a problem with F. moniliforme when grovm on a medium 
rich in carbohydrates (Nelson, 1992). Mycelial or pionnotal type mutants often lost virulence 
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and the ability to produce toxins. To avoid mutations, cultures were initiated from single 
conidia, grown in a low carbohydrate medium, and preserved by lyophilization or in liquid 
nitrogen. 
2. Liquid growth medium 
Fusarium moniliforme and F. proliferatum also produce FBs when cultured in LM. 
However, concentrations of FBs in LM are usually expressed in wet wt rather than DW 
which may result in an apparent lower mass. Jackson and Bennett (1990) inoculated 500 ml 
of a basal-salts vitamin-supplemented LM with F. moniliforme Northern Regional Research 
Center Peoria, IL (NRRL)-13616 which produced 0.1 mmoles FB,/L of LM after 29 d. The 
basal-salts consisted of 3.5 g NH4SO4, 2.0 g KH,P04,0.4 g MgS04«7H20, 16 mg 
MnS04*H20, and 90 g glucose/L of dHjO. The vitamin-supplement consisted of 500 |ig each 
of thiamin, riboflavin, pantothenate, niacin, pyridoxamine, and thiotic acid/L of dH^O. The 
culture was grown in a 1 L Erlenmeyer flask on a rotary shaker at 220 revolutions per min 
(rpm) and 28°C and the pH was maintained at 5.0 using 2N HCl or 2N NaOH. Lebepe-
Mazur (1993) inoculated 100 ml of basal-salts vitamin-methionine-supplemented LM with F. 
proliferatum M-5991 which produced 0.5 mmoles FB,/L of LM after 24 d of incubation. 
The vitamin-methionine-supplement consisted of 50 ^g each of folate, biotin, and vitamin 
B|2 and 250 mg of dl-methionine/L of dHiO. The cultures were incubated in 1 L screw 
capped flat bottles laid on their sides while shaking at 5 rpm on a rotary shaker without pH 
adjustment. These data suggested that adjusting the pH of the LM may result in reduced 
production of FBs by F. moniliforme or F. proliferatum. 
Blackwell et al. (1994) inoculated 50 ml of LM with F. moniliforme NRRL-13616 
which produced 0.5 mmoles FB,/L of modified Myro LM. The modified Myro LM consisted 
of 1.0 g (NH4),HP04. 3.0 g BCH2PO4, 0.2 g MgS04»7H20. 5.0 g NaCl. 40 g sucrose, and 10 g 
glycerin/L of HiO. Production of FB, in 250 ml Erlenmeyer flasks was greatest when the 
inoculum was increased fi-om 4.0 to 7.0% (v/v) or the volume of LM was increased firom 50 
to 75 ml. Miller et al. (1994) inoculated 9.3 L of the same LM in a 15 L stirred jar vessel 
with F. moniliforme NRRL-13616 which produced 0.4 mmoles FB,/L of LM after 10 d. Air 
was pumped into the fermentation vessel at 3.2 L/min. In the fermentation vessel, CO, 
production decreased and reducing sugars were consumed as the FB levels increased 
suggesting that FB production occurred during low respiration by F. moniliforme. The cell 
density of the F. moniliforme culture increased from 0 to 9.0 g DW solids/L after 10 d of 
incubation. The concentration of FB, produced, based on DW solids, was 40 mmoles FB,/kg 
DW solids. These data indicated that there was a 5-fold increase in FB, produced by F. 
moniliforme in LM than in SCM or SRM. 
Production of FBs from LM is better than from SCM or SRM as indicated by the FB 
concentrations based on DW. The SCM and SRM contained more solids than the LM which 
may have hindered the purification procedure of FBs. 
D. Fumonisin Analysis 
1. Fluorometry 
The structure of FBs does not allow for its direct detection using most analytical 
detectors such as an ultraviolet absorbance detector. Like sphingosine and amino acids, the 
primary amine group of FBs can be derivatized with fluorescent compounds and quantified 
using a fluorometric detector. .Analysis of FBs initially involves a clean-up procedure 
followed by derivatization with a fluorescent molecule such as o-pthaldialdehyde (OPA) and 
a reducing agent such as 2-mercaptoethanol (MCE) followed by C,g-HPLC with fluorometric 
detection. Previous work by Merrill et al. (1988) analyzed sphingosine, which is structurally 
similar to FBs, by derivatization with OPA containing MCE for at least 5 min, loading onto a 
C,g-HPLC column, elution with MeOH:5.0 mM KH2PO4 at pH 7.0 (90:10), and 
quantification using a fluorometer with an excitation wavelength (?Lex) of 340 nm and an 
emission wavelength (>.em) of455 nm. Similarly, FB, and FB, were derivatized with OPA 
containing MCE for I to 2 min, loaded onto a Cig-HPLC column, eluted with MeOH:0.1 M 
NaHiPO^ (80:20) pH 3.3, and quantified using a fluorometer with an Xe\ of 335 nm and an 
?uem of440 nm (Shephard et al., 1990). This procedure has been accepted, with slight 
modification of mobile phase to MeOH:0.1 M NaH2P04 (77:23) pH 3.3, as an A.O.A.C. 
Official Method 995.15 for quantification of FB„ FB,, and FB3 that have been extracted and 
cleaned-up from com (Sydenham et al., 1996b). Rice and Ross (1994) reported FB,, FB,, 
and FB3 were derivatized with OPA and MCE for 10 min, loaded onto a C,g-HPLC column, 
eluted with a ACN:50 mM KH2PO4 at pH 3.3 (40:60), and quantified using a fluorometer 
with an Xex of 335 nm and an A.em of 440 nm. Poling and Plattner (1996) reported FB, and 
FB4 were derivatized with OPA and MCE for 1 to 2 min, loaded onto a C,g-HPLC column, 
and eluted with MeOH:H20:0.1 M NaH2P04 adjusted to pH 3.35 A (60:40) and B (80:20) at 
25% A for 1 min, a linear gradient to 100% B for 15 min, and 100% B for 5 min. The OPA-
FB derivatives were quantified using a fluorometer with an A.ex of 334 nm and an A,em of 440 
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nm. Thakur and Smith (1996) modified the conventional HPLC procedure for separation of 
the OPA-FB derivatives by leaving the buffering-salts out of the mobile phase. Samples 
containing FB,. FB,, HFB,, HFB,, and partially hydrolyzed FB, (PHFB,) were derivatized 
with a commercial reagent OPA-reducing agent kit for I min, loaded onto a double-end-
capped Cjg-HPLC column, eluted with ACNiHjO'.acetic acid (40:59; 1) and (60:39:1) gradient 
0% to 100% of the latter phase in 9 min. The OPA-FB derivatives were quantified using a 
fluorometer with an A.ex of 255 nm and an X.em of442 nm. This HPLC mobile phase for FB 
separation was reported to be better than the conventional buffering-salts mobile phase 
because it was more appropriate for on-line liquid chromatography (LC)-MS analysis and 
required less time for column equilibration. Miyahara et al. (1996) reported FB, and FB, 
were derivatized with OPA containing N-acetyl-L-cysteine in an in-line reaction coil and 
loaded onto an ion pair LC. This derivatization procedure produced a more stable derivative 
than the OPA containing MCE procedure (Miyahara et al., 1996). The OPA-FB derivatives 
were quantified using a fluorometer with an Xex of 336 nm and an Xem of 460 nm. 
Holcomb et al. (1993) reported that FB, was derivatized with (9-fluorenyhnethyl) 
chloroformate (FMOC) for 30 sec followed by pentane extraction, loaded onto a C,g-HPLC 
column, and eluted with MeOHrcitrate buffer A (30:70) and B (70:30) at a linear gradient 
from 10 to 40% B over 9 min followed by a linear gradient to 100% B in 1 min. The FMOC-
FB derivatives were quantified using a fluorometer with an Xex of 263 nm and an A.em of 313 
nm. 
Ware et al. (1993) compared amine derivatizing reagents, naphthalene-2,3-
dicarboxaldehyde (NDA), OPA, phenyl isothiocyanate, fluorescamine, and 
nitrobenzoxadiazole. for their stability after derivatization with the amine group on FB,. The 
derivatizing reagent with the best stability was NDA, however, it involved a complex 
procedure of heating FB,, NDA, and cyanide at 60°C for 15 min. However, the NDA-FB, 
derivative retained 90% of its fluorescence after 10-h while the OPA-FB, derivative retained 
only 33%. Phenyl isothiocyanate and fluorescamine were less effective in their ability to 
form a stable derivatized FB, compound. The NDA-FB, derivative was loaded onto a C ,g -
HPLC column, eluted with ACNiHiOracetic acid (55:45:1), and quantified using a 
fluorometer with an Xex of 410 nm and an Xem of440 lun. 
Rottinghaus et al. (1992) developed a rapid procedure screening samples for the 
presence of FB compoimds. C,g-Thin layer chromatography (TLC) plates were spotted with 
FB, and FBj, developed with MeOH:4% aqueous KCl (3:2), and sprayed with fluorescamine. 
The fluorescamine derivatized with the amine group of FB, and FB,. After drying the 
fluorescamine-FB compounds were observed under long-wave ultraviolet (UV) light as 
bright yellowish-green bands. 
The OPA-FB, derivatization method has been the method of choice for FB 
identification and quantification by researchers. This method is relatively simple, cheap, and 
reproducible. The NDA-FB, derivative was shown to be more stable than OPA-FB, but 
appeared to be more a complicated procedure. Identification of FBs by TLC is relatively 
simple, cheap, and quick but, is not usefiil for quantification of FBs. 
2. ELISA 
Detection of FBs by an enzyme-linked immunosorbant assay (ELISA) involves 
monoclonal or polyclonal antibodies raised against FBs. When com and com based foods 
were quantified for FB, by monoclonal antibody competitive direct-ELISA. greater levels of 
FB, were obtained compared to OPA-FB, fluorometric detection (Pestka et al., 1994; Tejada-
Simon el al, 1995; Sydenham et al., 1996a; Sutikno et al., 1996). Similar results were 
observed by Shelby et al. (1994) in FB, quantified in com using monoclonal antibody 
competitive indirect-ELISA compared to TLC. These data suggested that compounds that 
were structurally related to FBs were detectable only by an ELISA. 
Yeung et al. (1996) quantified the amount of FB, in com by polyclonal antibodies 
CD-ELISA (PA-CD-ELISA) but did not compare their results to other FB, detection 
procedures. Schneider et al. (1995) developed a qualitative 10 min detection method for FB, 
using a noncompetitive anti-FB, antibodies enzyme linked immunofiltration assay. 
Compared to fluorometric analysis, the ELISAs have the potential to provide quick 
results where a large number of samples can be qualitatively screened for FBs at one time. 
These ELISAs are applicable for field and industry use. However, due to cross reactivity 
with other FBs and structurally related compounds, the amounts of FBs detected in com and 
food samples by ELISAs have been greater than the amounts detected by conventional 
HPLC-OPA derivatized methods. 
3. Other analytical methods 
Due to the structure of FBs, their direct detection by UV detectors has not been 
reported. Alberts et al. (1993a) derivatized FB,, FB,, and FBj with maleic anhydride and 
quantified them using HPLC with an UV detector at 240 nm. However, the FB-maleyl 
derivatives had low end detection limit of 112-140 |j.moles FBs/g of SCM compared to 1-18 
nmoles FBs/g SCM for OPA-ME analysis (Sydenham et al., 1996) and 55-83 pmoles FBs/g 
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SCM for ELISAs (Schneider et al., 1995). Wilkes et al. (1995) quantified FBs with 
evaporative light-scattering detection (ELSD) after HPLC separation without derivatization. 
However, the ELSD could only detect about 1.7 (imoles FBs/g of SCM and the standard 
curves are not linear. Due to its non-invasive analysis of FBs, the ELSD was practical for 
semi-preparative purification of FBs. The method of FB detection by silica-TLC 
(Ackermann, 1991) was enhanced by a spectrophotodensitometer detector (Bars et al.. 1994) 
making silica-TLC analysis of FBs applicable for quantitation having a low end detection 
limit of42-70 mmoles FBs/g of SCM and 4-7 mmoles FBs/g of purified extracts. 
Other methods that have reported to characterize FBs by mass spectrometry (MS) 
include continuous flow fast atom bombardment and ion spray-MS (Mirocha et al., 1992), 
electrospray-MS (Poling and Plattner, 1996), negative-ion thermospray-MS (Thakur and 
Smith, 1994), and particle-beam-MS (Young and Lafontaine, 1993). 
E. Fumonisin Clean-Up 
1. Solid matrices 
For quantification in com and com-based foods, FBs need to be cleaned-up so they 
can be identified using a detection method. Hopmans and Murphy (1993) cleaned-up FB,, 
FB,, FBj, and HFB, fi-om com based foods by extraction with 50% ACN and elution fi-om a 
C,g-SPE cartridge. Rice et al. (1995) cleaned-up FB„ FB,, and FB3 fi-om com, poultry feed, 
and SCM by extraction with 50% ACN and elution from a C,g-SPE cartridge. Miyahara et 
al. (1996) cleaned-up FB, and FB, from com and com-based foods by extraction with 50% 
ACN and elution from C,g-SPE and strong anion exchange (SAX)-SPE cartridges. 
Sydenham et al. (1996b) cleaned up FB,, FB,, and FB, from com by extraction with 75% 
MeOH and elution from a SAX-SPE cartridge. This last procedure has been accepted as an 
AO AC Official Method as a pre-quantification clean-up procedure for determination of FB,. 
FBj, and FBj levels in com (Sydenham et al., 1996b). However, HFBs will not be retained 
on the SAX-SPE column and are missed by the AO AC method. Ware et al. (1994) cleaned-
up FB, and FB, from com by extraction with 80% MeOH and elution from an 
immunoaffinity Fumonitest-LC column. Selim et al. (1996) cleaned-up FB, from com. com 
dust, and SCM by extraction with supercritical CO, (SC-CO,). The SC-CO, fluid extraction 
removed 40-fold more FB, from the com and com dust, was faster, and was more 
reproducible than extraction with ethyl acetate 2 times followed by 75% MeOH 3 times. 
Clean-up procedures are similar to purification procedures only on a smaller scale with the 
use of cartridges rather than columns. 
F. Fumonisin Purification 
1. Solid matrices 
Purification of FBs is the first step in FB quantification and usually involves 
extraction from a solid matrix with a solvent, such as MeOH or ACN, followed by 
chromatography and finishing with purified dry solids for weight determination. Cawood et 
a/. (1991) purified FB„ FB,, FBj, and FB4 produced by F. moniliforme MRC-826 on SCM 
by extraction with 75% MeOH and elution from XAD-2-, silica gel-, and C,8-LC to obtain 
>90% pure FBs with 40% yield. Meredith et al. (1996) purified FB, produced by F. 
moniliforme MRC-826 from SRM by extraction with 50% acetonitrile (ACN) and elution 
from a C,8-LC column and 2 cyano-LC-cartridges to obtain >95% pure FB, with a recover\' 
of 77%. Poling and Plattner (1996) purified FB, and FB4 to >90% FB, and FB4 with >95% 
recovery produced by F. moniliforme from SCM by extraction v^ath 50% ACN. elution from 
a NHj-solid phase extraction (SPE) cartridge with 5% acetic acid in MeOH, and elution from 
a Cjg-SPE cartridge with increasing concentrations of ACN. 
Monomethyl and dimethyl esters of FB, and FB,, formed as artifacts from extractions 
of FBs from SCM with MeOH, may interfere with the purification of FB,, FB,, and FB4 
(Gelderblom et al., 1992). Monomethyl and dimethyl esters have not been reported to be 
produced during extraction of FBs with acetonitrile (ACN). In addition, the extraction of 
FB,, FB,, and FB3 from SCM with 50% ACN was 3-fold greater than 75% MeOH after 8-h 
(Nelson et al., 1994; Rice et al., 1995). Due to the reported formation of artifacts and better 
ability to extract FBs from SCM, ACN may be a better solvent than MeOH for FB extraction 
from SCM. 
Complicated matrices such as biological tissues require the use of a chelating agent 
such as ethylenediaminetetraacetic acid (EDTA) to extract impurities associated with the 
FBs. Shephard et al. (1994b) cleaned-up FB, from primate feces by extraction of impurities 
with 0.1 M EDTA 6 times and elution of the FB, from a C,g-SPE cartridge. Hopmans et al. 
(1997) cleaned-up FB„ HFB„ and FB,-FRU from rat feces by extraction of the impurities 
with 0.1 M EDTA 9 times and elution from a C,g-SPE cartridge. 
The FBs have been purified from solid matrices by extraction and LC to >95% purity 
and up to 95% recovery. 
2. Liquid matrices 
Purification of FBs from liquid matrices does not require solvent extraction like that 
of solid matrices. In addition, the liquid matrices do not apparently contain as many 
lipophilic compounds as solid matrices which co-purify with FBs during LC (Jackson and 
Bennett, 1990). Miller et al. (1996) purified FB, produced by F. moniliforme NRRL-13616 
in LM to 97% purity with 89% yield by ion-exchange, silica gel, and C,g-LC. Lebepe-Mazur 
(1993) purified FB, produced by F. proliferatum M-5991 in LM to >90% purity with 40% 
yield by XAD-2, silica gel, and Cjg-LC. The use of ion-exchange to purify FBs may result in 
increased purities of FB,. 
G. Isotope Labeling of Fumonisin B, 
L Deuterium labeling 
Labeling FB with isotopes, such as deuterium ("H), can be helpful for understanding 
the production of FB by F. moniliforme and identify possible radiolabeling substrates. 
Isotope or radiolabeled FB, is needed for animal toxicity studies. Plattner and Shackelford 
(1992) and Plattner and Branham (1994) added [^H3]-(CH3)-L-methionine to LM cultured 
with F. moniliforme M-2326 resulting in the production of ["H3]-(C-12, 16)-FB, (Fig. 1). 
Three or 6 'H atoms were incorporated into FB, suggesting that the CH, group of methionine 
was incorporated into one or both of the CH3 groups at the C-12 and C-16 positions on the 
FB, backbone. Methionine, a substrate used by many fungal methyl transferases (Plattner 
and Shackelford, 1992), stimulated the production of FB, when added to LM cultured with F. 
moniliforme and incubated for 13 d. These data suggested that methionine could be used as a 
substrate for radiolabeling FBs. 
2. "C Labeling 
Alberts et al. (1993b) added ['^C]-(CH3)-L-methionine to SCM cultured with F. 
moniliforme MRC-826 which resulted in the production of ['^C]-(C-12, 16)-FB| supporting 
the observation of Plattner and Shackelford (1992) and Plattner and Branham (1994). that 
methionine supplied the CHj groups located on the C-12 and C-16 positions of the FB, 
backbone. Blackwell et al. (1994) added ['^C]-(C-2)-acetate to LM cultured with F. 
moniliforme NRRL-13616 resulting in the production of ['^C]-(C-4,6, 8, 12, 14, 16, 18, 20)-
FB,. When ['^C]-(C-l)-acetate was added to LM cultured with F. moniliforme NRRL-13616, 
['^C]-(C-3, 5, 7, 9,11, 13, 15, 19)-FB, and a ['^C]-carboxyl in the TCA groups were 
identified. When ['^C]-(CH3)-L-methionine, ['^C]-(C-5)-L-glutamate, and ['^C]-(C-3)-serine 
were added to LM cultured with F. moniliforme NRRL-13616, ['^C]-(C-12, 16)-FB,, ['^C]-
TCA groups, and ['^C]-(C-1)-FB, were identified, respectively. ['^C]-(C-3)-L-Alanine was 
also reported by Blackwell et al. (1996) to produce ['^C]-(C-1)-FB,. These data suggested 
that the long chain FB-backbone may have been derived from the condensation of acetyl-
CoA units resulting in the even label throughout the FB molecule during polyketide 
synthesis. Radiolabeled acetate may be a better substrate for radiolabeling FB because more 
carbons are labeled per molecule of FB. 
3. '""C Labeling 
Radiolabeling FB with ['•*€] can be useful for animal toxicity studies. The amount of 
incorporation of radioactivity that is incorporated into a molecule can be expressed as 
specific activity (SA) having the units of milli-Curie (niCi)/mmoie Alberts et al. (1993b) 
added 50 mg L-methionine and 200 |iCi ['^C]-(CH3)-L-methionine to 30 g of SCM cultured 
with F. moniliforme MRC-826. The F. moniliforme produced ['"'Cj-FB which was purified to 
14 mmoles FB/kg DW with a SA of 0.04 mCi/mmole. The '^C-methionine was added during 
logarithmic phase of FB, production from 3 to 11 d of incubation and was incorporated into 
the C-21 and C-22 positions of the FB, backbone. However, when 250 mg sodium acetate 
and 125 ^iCi of ['^C]-acetate were added to 30 g SCM containing F. moniliforme, the SA of 
the purified FBs was only 0.01 mCi/mmole. These data suggested that when 250 mg sodium 
acetate were added to 30 g SCM, F. moniliforme decreased the production of FB,. 
Lebepe-Mazur (1993) incubated 500 ml of LM containing F. proliferatum M-5991 
for 8 d, added 100 jaCi ['''C]-(CH3)-L-methionine, and harvested after 12 d. The F. 
proliferatum produced ['""CJ-FB, which was purified to 54 [amoles of 85% pure ['''C]-FB, 
with a SA of 0.07 mCi/mmole. Norred et al (1993) added 1 mCi of ['''C]-(CH3)-methionine 
to 100 ml of LM cultured with F. moniliforme M-2326 and harvested after 10 d of 
incubation. The F. moniliforme produced ['"CJ-FB, which was purified to 55.5 ^moles ['"CJ-
FB, (>95% pure) with a SA of 0.74 mCi/mmole. Blackwell et al. (1994) added 0.1 mCi [1,2-
'"CJ-acetate to 50 ml of LM cultiu-ed with F. moniliforme NRRL-13616/d between 7 and 14 d 
of incubation and harvested after 17 d. The F. moniliforme culture produced ['"C]-FBs which 
were purified to 36 [imoles FBs with a SA of 0.65 mCi/mmole. These data suggested 
different methods for ['"C]-labeling of FBs in LM cultures of F. moniliforme. 
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H. Fumonisin Toxicity 
1. History 
Prior to 1988, SCM containing cultures of F. moniliforme were known to induce 
ELEM and equine hepatotoxicity, PPE, rat liver cancer, and were associated with human 
esophageal cancer in South Africa (Marasas, 1996). During 1988 to 1991, the FBs were 
isolated, characterized, and confirmed to be inducers of ELEM, PPE, and liver cancer in 
horses, swine, and rats, respectively (Marasas, 1996). 
Epidemiological studies on FBs have shown that FBs exist in animal and human food 
and suggest a correlation between FB consumption and human esophageal cancer. Castella 
et al. (1996) found that over 97% of F. moniliforme strains isolated from poultry feed 
produced FB,. Fumonisin B, was present in 89% of the com samples collected from 
different regions of Costa Rica (Viquez et al., 1996). The FBs are the major mycotoxin 
contaminants of com-based foods in Eastern and Southern Africa (Doko et al., 1996). Com 
samples, taken from households of Linxian China in areas that had high incidences of human 
esophageal cancer, were found to contain an average of 103 and 48 (amoles FB,/kg moldy 
and non-moldy com, respectively (Chu and Li, 1994). Although inconclusive, these data 
suggested a possible correlation between FBs and human esophageal cancer. Chu and Li 
(1994) suggested that the carcinogenic potential of FBs may be increased by the ability of F. 
moniliforme to produce carcinogenic nitrosamines from nitrate and precursor amines. 
Marasas et al. (1988) dosed 2 horses (15 years old [y], 425 kg BW; 15 y, 385 kg BW) 
by gavage with a com diet containing 3.5 and 1.75 ^moles FB|/kg BW/d for 6 d, 
respectively. Both horses developed ELEM without signs of demyelinization. The 3.5 
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fimoles FB,/kg BW/d dose induced fatal hepatosis, mild brain lesions, and elevated activities 
of aspartate transaminase (AST), gamma-giutamyltransferase (GGT), lactate dehydrogenase 
(LD), and total bilirubin (TB) in the horse up to 4 d after the treatment terminated. The 1.75 
jimoles FB,/kg BW/d dose induced mild hepatosis, severe brain lesions, and elevated 
activities of AST, GGT, and LD in the horse 3 d after commencement of the treatment. In a 
second experiment, ELEM was induced in a horse by intravenous injections (iv) of 0.17 
|j,moles FB, (92 % pure)/kg BW/d for 7 d. The FB, used in the iv dose was produced by F. 
moniliforme MRC-826 on SCM. Biochemical changes in the horse included elevations of 
AST and GGT up to 4 d after the treatment terminated. Kellerman et al. (1991) dosed a filly 
(0.75 y, 150 kg BW) and a colt (1.2 y, 190 kg BW) by gavage with 12.4 mmoles FB, (50% 
pure) over a period of 33 d and 1.7 mmoles FB, (95% pure) over a period of 29 d, 
respectively, which induced ELEM in both horses. Serum AST levels in the filly and serum 
GGT levels in the colt were elevated. No other changes in biochemical markers, AST, GGT. 
LD, and TB, were observed. The kidneys from each horse were swollen and grayish-yellow 
in color. In the final treatments, the horses developed clinical signs typical of ELEM 
(including stumbling, apathy, tremors, and inability to eat). The total dose required for the 
appearance of the initial clinical signs was 4.1 mmoles FB, (50% pure) for the filly and 8.3 
mmoles FB, (95% pure) for the colt. Indications of ELEM were apparent in the left fi-ontal 
lobe of the filly and the left firontal to occipital lobes of the colt. Wilson et al. (1992) fed 
com containing 20.8, 0, 30.5, 0, and 30.5 ^moles FB,/kg diet/d for 130, 30, 13, 7, and 58 d, 
respectively, to a gelding horse (4 y, 152 kg BW) which induced ELEM and death in the 
horse. This diet regimen was designed to determine on the minimum dose of FB, that was 
toxic to this horse. However, the com also contained 31 (imoles of FB^/kg com. Prior to 
death, the horse showed typical symptoms of ELEM (aggression, ata.\ia, and confusion). 
During the final treatment, the dosage rate was 0.25 i^moles FB|/kg BW/d. Within 9 d of 
death, the horse experienced increased serum TB, direct bilirubin (DB), alkaline phosphatase 
(ALP), GGT, and bile acids. Three other horses of similar age survived the treatments and 
were euthanized after 146 d into the final treatment. They did not develop ELEM or 
abnormal serum chemistr)' levels, but showed typical physical symptoms of ELEM and had 
histopathological-brain lesions. In a second experiment reported by Wilson et al. (1992), 5 
horses fed a low fat com diet containing 2.0 jimoles FBs/d for 122 d followed by a normal 
com diet containing 4 |amoles FBs/d for 58 d. These horses survived the FB, treatments 
without abnormal serum chemistry levels. However, they showed typical physical symptoms 
of ELEM and developed histopathological-brain lesions. These data support the findings that 
FB|, purified or contained in com, caused ELEM in horses at a minimum level of 0.17 to 5.5 
jimoles FB,/kg BW for 7 d. When dosed by iv, FB, was 10-fold more toxic to horses than 
when dosed by gavage suggesting that FB, was only partially absorbed when consumed by 
these horses. These FB-treated horses showed signs of liver or kidney toxicity based on 
serum chemistry data. 
Harrison et al. (1990) fed com containing 215 jimoles FB,/kg diet for 7 d to young 
swine (16-24 kg BW) which caused PPE and death in the swine. The FB, was produced by a 
fungus identical in morphology to F. moniliforme MRC-826. In a second experiment, a 
young pig (7-8 kg BW) dosed by iv with 0.5 (amoles of FB, (>95% pure)/kg BW/d developed 
PPE and died after 5 d. Pathological lesions in the lungs were found in the PPE affected pigs 
with typical PPE symptoms including the presence of clear foamy liquid in the trachea and 
bronchi, air-clotting golden-yellow liquid in the thoracic cavity, and interlobular edema of the 
lung. However, in a third experiment reported by Harrison et al. (1990). a pig dosed by iv 
with 0.24 i^moles of FB, (>95% pure) and a pig dosed by iv with 0.4 |imoIes of FB, (>95% 
pure)/kg BW/d for 7 d, did not develop PPE. Osweiler et al. (1992) fed a com diet 
containing 23 |imoIes FB,/kg diet to weanling pigs (7-15 kg BW) causing PPE after 5 d. The 
FB, was produced by F. moniliforme MRC-3033. Prelusky et al. (1996) found FB, to 
accumulate in the liver and kidneys of pigs (6-8 weeks [wk] old. 9-13 kg BW) fed 4 fimoles 
['''C]-FB,/kg diet for 12 d followed by 3 fimoles ["'C]-FB,/kg diet for 12 d. The ['"CJ-FB, 
was produced by F. moniliforme NRRL-13616. These data suggested that FB, may have 
caused PPE after these pigs consumed 3 jamoles FB,/kg diet for 12 d. When pigs were dosed 
by iv, FB, was almost 20-fold more toxic to pigs than when dosed by gavage suggesting that 
FB, was not well absorbed by the GI tract of these pigs. 
Motelin et al. (1994) fed a com screenings diet which was found to contain 243 
fimoles FBs/kg diet to male weanling pigs (6-13 kg BW) inducing PPE after 14 d. However, 
no PPE symptoms were observed in pigs fed 139 lamoles FBs/kg diet. These data suggested 
that PPE in swine may have been caused by the consumption of diet containing 139-243 
fimoles FBs/kg diet. The presence of FB,, at about 30% of the total FBs, may have played a 
role in the toxicity of the FB-containing diet. There has been little work comparing PPE 
toxicity of FB, and FB,. 
Smith et al. (1996) fed pigs a com diet containing 49 fimoles HFB,/kg BW/d for 7 d. 
The HFB, was synthesized from FB, produced by F. moniliforme MRC-826. After 8 d, the 
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pigs were catheterized and their right atriums were infused with Monastral Blue or 
Pseudomonas aeruginosa to measure the efficiency of pulmonary clearance. This HFB, level 
may have inhibited pulmonary intravascular macrophages from clearing particulates and 
bacteria fi'om the circulation which, could have made these pigs vulnerable to infectious 
diseases. These data suggested that HFB, is toxic to pigs and could have potentially caused 
PPE. 
After FB, has been identified and purified, it has been reported to cause ELEM and 
PPE. However, the mode of toxicity and the ability to target different organs in different 
animals, such as the brain of horses and the lungs of pigs, has not been reported. The 
implications this has for humans is unclear. So far, FB consumption has been associated with 
human esophageal cancer only by epidemiological studies. 
2. Alteration of sphinganine and sphingosine metabolism 
Fumonisins inhibit ceramide synthase, the main enzyme involved with converting 
sphinganine to ceramide (Merrill et al., 1993) during sphingolipid metabolism in mammals. 
Once formed, ceramide may then be converted to sphingosine or other sphingolipids. Levels 
of sphingosine are only slightly increased in cells exposed to FBs. This may be due to the 
breakdown of complex sphingolipids. Therefore, inhibition of ceramide synthase could 
result in the accumulation of sphinganine and an increase in the sphinganine/sphingosine 
ratio of mammalian cells (Merrill et al., 1993). Riley et al. (1993) observed increased 
sphinganine levels, an increase in the sphinganine/sphingosine ratio, and a slight increase in 
sphingosine in male and female Sprague-Dawley rats (3-5 wk old) fed 20 ^moles FB, (>99% 
pure)/kg diet for 4 wk. The FB, was produced by F. moniliforme MRC-826 on SCM. The 
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kidneys of the male and female rats and urine from the male rats, fed ^0 [amoles FB,/kg 
diet, had significantly higher sphinganine levels than their respective controls. The 
sphinganine levels from the urine of female rats were significantly increased when fed >67 
[imoles FB,/kg diet. Ultrastructural damage was observable in the kidneys from the male rats 
fed ^0 famoles FB,/kg diet and in female rats fed >67 fimoles FB,/kg diet. A similar pattern 
of tissue damage was observed in the male and female rat livers. Elevated sphinganine levels 
and an increase in the sphinganine/sphingosine ratio observed in the urine of these rats may 
have been due to FB,-induced kidney or liver toxicity. The male rats appeared to be slightly 
more sensitive to FB, than female rats as perceived by the urine and ultra-structural damage 
data. These data supported the theory that FB, inhibited ceramide synthase because 
sphinganine was increased in rats dosed with FB,. 
Martinova and Merrill (1995) dosed BALB/c mice by iv with 0.028 fimoles of FB, 
(>95% pure)/kg BW/d for 5 d resulting in a 294-fold increase in liver sphinganine and a 6-
fold increase in liver sphingosine. These data suggested that FB, produced similar signs of 
liver toxicity in mice as those seen in rats. 
Weibking et al. (1993) fed ICQ fimoles FB,/kg diet to broiler chicks for 21 d and 
observed a 3-fold increase in serum sphinganine levels and a 6-fold increase in the 
sphinganine/sphingosine ratio. The FB, was produced by F. moniliforme M-1325 on com 
and extracted with acetonerchloroform (75:25). These data suggested that chickens may be 
less toxic to FB, than rats. 
The FB, (>95% pure) concentration causing 50% inhibition of ceramide synthase in 
mouse brain microsomes (IC50) was 0.075 |iM FB, (Merrill et al., 1993). Fumonisin B, was 
shown to competitively inhibit ceramide synthase with sphinganine and stearoyl-CoA as 
substrates. Mouse brain microsomes produced '•*C-sphingolipids when incubated with ['•*€]-
serine. However, when similar mouse brain microsomes were incubated with ['''C]-serine 
and 25 FB,, the amount of ['"'CJ-sphingolipids were decreased. This same dose of FB, 
caused free sphinganine to increase 20-fold within 24-h while no change occurred in 
sphingosine concentrations from the mouse brain microsomes. Harel and Futerman (1993) 
treated rat hippocampal nevircns with 10 FB, (>95% pure) in vitro resulting in an 
inhibition of sphingolipid synthesis after 2 to 3 d of incubation. Control neuron cells 
increased their axonal length from 170 to 240 |im, while no increase in axonal length were 
observed in FB, treated neurons. Furthermore, when ceramide was added to FB, treated 
neurons, an increase in axonal length was observed indicating that FB, toxicity to these 
neurons may be due to inhibition of ceramide synthesis. These data suggested that FB, 
affected sphingolipid metabolism of mouse brain microsomes and the axonal growth of rat 
neuron cells. 
Fumonisin B, affects kidneys, livers, and brains of rats and or mice as noted by tissue 
damage and increases in sphinganine and the sphinganine/sphingosine ratio associated wdth 
these organs. These data suggested that FB, altered sphingolipid metabolism which may be 
the mechanism for its toxicity. 
3. Liver and kidney toxicity 
Animal dosing of FBs, intraperitoneally or orally, may result in different 
bioavailabilities due to the low absorptions of FBs by the GI tract of mammals. Bondy et al. 
(1996) dosed male Sprague-Dawley rats (120-170 g BW) intraperitoneally with 14 iimoles 
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FB, (98% pure)/kg BWVd causing liver and kidney toxicity and a reduction in 8 W. food 
consumption, and feces production after 4 d. Hepatotoxicity was correlated with 
histopathology. Nephrotoxicity was correlated with an elevated blood urea nitrogen and with 
changes in kidney morphology. In addition. FB, was toxic to the immune system based on 
reduced thymus weight, disseminated thymic necrosis, and elevated serum immunoglobulin 
M levels. Martinez-Larranaga et al. (1996) administered male Wistar rats (200-210 g BW) 
with 0.35 lamoles of FB, (>95% pure)/kg BW/d for 6 d intraperitoneally which caused an 
increase in the activity of microsomal and peroxisomal enzymes. However, no metabolites 
of FB, were found confirming the findings of Cawood (1994) that rat liver enzymes did not 
modify FB,. Suzuki ei al. (1995) dosed male Sprague-Dawley rats (120-170 g BW') with 
10.4 {.imoles FB, (98% pure)/kg B\V/d for 4 d intraperitoneally resulting in kidney toxicity as 
determined by increased urine volume, decreased urine osmolality, proteinuria, enzymuria. 
and ion transport. These data suggested that FB,. administered orally or intraperitoneally. 
may induce liver and kidney toxicity in rats. Rats dosed intraperitoneally with FB, 
developed an acute toxicity to FB,. However, rats dosed by gavage were not acutely 
intoxicated, suggesting that ver\' little of the FB, may have been absorbed by the GI tract of 
these rats. 
Gelderblom et al. (1991) fed 69 j.imoles FB, (>90% pure)/kg diet to male BD-IX rats 
(70-80 grams [g] BW) for 26 months causing kidney toxicity in the rats. The FB, was 
produced by F. moniliforme MRC-826. Elevated serum levels of AST. glutamine serum 
transferase (GST), and TB were observed in the rats. However, serum levels of ALT and 
ALP were not elevated. Other toxic effects (esophageal, heart, and fore-stomach lesions). 
previously associated with rats fed com diets containing FBs were not observed. Osweiler et 
al. (1992) reported subacute hepatotoxicosis with hepatocellular necrosis, 
hepatomegalocytosis, and an increased number of mitotic figures in livers of weanling swine 
(7-15 kg BW) fed a com diet containing 167 ^moles of FBs/kg diet for 6 d. Similar results 
of hepatotoxicosis occurred in 2 other weanling swine (7-15 kg BW) dosed by iv with 1.1 
lamoles of FB, (98 % pure)/kg BW/d for 14 d. These swine became cachextic and, after 12 d. 
icterus (jaundice) was obvious in the skin, sclera (white portion of the eyes), and oral mucous 
membranes. Haschek et al. (1992) administered 11 jimoles of FB, (>95% pure)/kg BW/d for 
9 d to a pig (4 wk old) by iv causing liver (hepatocyte disorganization and necrosis) toxicity. 
Similar findings resulted in another pig (4 wk old) dosed by iv with 6.4 lamoles FB, (>95% 
pure)/kg BW/d for 4 d. Fumonisin B, caused an increase in the activity of serum liver 
enzymes (AST, ALP, GGT), TB, and cholesterol resulting in liver toxicity in these animals. 
Motelin et al. (1994) fed a com diet, that was found to contain 139 famoles of FBs/kg 
diet, for 14 d to male weanling pigs (6-13 kg BW) which induced liver toxicity. Increases in 
serum bilimbin and cholesterol concentrations and in GGT, ALP, alanine amino transferase 
(ALT), AST, and arginase (ARG) activities were observed in the pigs. Based on regression 
analysis of the 14 d serum chemistry profiles (with ALP being the most sensitive), the NOEL 
for liver toxicity in the FB fed swine was <17 |imoles of FBs/kg diet. Liver enzyme 
biomarkers may be a more sensitive assay for FB toxicity than adverse toxic effects in swine 
after consumption of FBs. For instance, the NOEL which Motelin et al. (1994) found to 
cause PPE in swine fed com screenings for 14 d was 243 |j,moles of FBs/kg diet. However, 
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the FBs consumed by the swine may have induced biomarkers of liver toxicity when the 
swine consumed <17 ^moles of FBs/kg BW. 
Edrington et al. (1995) intraruminally gavaged com containing 15 i^moles of FBs/kg 
diet/d to crossbred Suffolk x Rambouillet wether ruminant-lambs (32 kg BW) for 4 d which 
induced liver damage. The blood serum liver enzyme (ALP, GGT, AST, and LDH) activities 
and liver and kidney damage indicators (cholesterol, triglycerides, urea nitrogen, and 
creatinine) were increased in the FB treated lambs compared to control lambs. However, 
lambs developed more severe toxic symptoms such as tubular nephrosis, mild hepatopathy, 
diarrhea, lethargy, decrease in feed intake, and death, when gavaged with com containing 61 
lamoles of FBs/kg diet/d for 4 d. Osweiler et al. (1993) reported increased activity of serum 
enzymes (AST. GGT, and LDH) and serum bilirubin and cholesterol concentrations in 6 
crossbred Limousine x Angus-Hereford ruminant steer calves (230 kg BW) fed a com diet 
containing 205 [imoles of FBs/kg diet for 31 d. The FBs were produced by F. moniliforme 
culture on com. All of the calves experienced impaired lymphocyte blastogenesis and two of 
the calves developed mild microscopic liver lesions. These data suggested that FBs were 
acutely toxic to liver and kidneys of ruminant lambs and, to a lesser extent, ruminant steer 
calves. 
Fumonisins caused an increase liver and kidney toxicity biomarkers in nonruminants. 
rats and pigs, and ruminants, lambs and steers. However, FBs were at least 14-fold less toxic 
to steers than lambs suggesting that bovine may absorb less FBs than lambs. 
37 
4. Developmental toxicity 
Floss (1994) administered 11 iimoles FBs/kg BW/d to 8 d post-mated pregnant 
Syrian hamsters by gavage for 3 d resulting in prenatal fetal death. The FBs were produced 
by F. moniliforme M-1325 on SCM, extracted with water, and filtered. The FB-dosed 
hamsters had decreased BW gains and serum bilirubin levels compared to control hamsters. 
There were no differences in fetal BW, numbers of prenatal deaths, or resorptions in 8 d post-
mated pregnant Syrian hamsters gavaged with ^8.3 jimoles FBs/kg BW/d for 3 d. Serum 
AST activities between FB, treated and control dams were not different indicating that the 
fetal deaths were not induced by liver toxicity in the hamster dams. Floss et al. (1994), 
administered 25 (imoles FB, (98% pure)/kg BW/d to 9 d post-mated pregnant Syrian 
hamsters by gavage resulting in prenatal fetal death. The FB, was produced by F. 
moniliforme M-1325 on SCM. In a similar experiment, reported by Floss et al. (1994), 9 d 
post-mated pregnant Syrian hamsters were gavaged with 31 lamoles of FBs/kg BW/d for 2 d 
which also resulted in prenatal fetal death. The FBs were produced by F. moniliforme M-
1325 on SCM, extracted with water, and filtered. These FB doses that were toxic to femses 
did not induce clinical maternal intoxication confirming the findings of Floss (1994) that the 
fetal deaths were not induced by liver toxicity in hamster dams. Lebepe-Mazur (1993) 
administered 84 |imoles FB, (80% pure)/kg BW/d to 9 d post-mated pregnant Fisher rats by 
gavage for 5 d resulting in suppressed fetal growth and bone development. The FB, was 
produced by F. proliferatum M-5991 in SCM. 
Javed et al. (1993) injected 1 and 10 d old fertile chicken eggs with 1, 10, or 100 
lamoles FB, (>95% pure)/egg resulting in embryo toxicity. Mortalities of chicken embryos 
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from 1 d old FB,-treated eggs were 50, 70, and 100%. respectively, and from 10 d old FB,-
treated eggs were 30, 60, and 90%, respectively. These data suggested that FB, was less 
toxic to the 10 d old chicken embryos than the 1 d old embryos. 
In summary, these data suggested that consumption of FBs was teratogenic to 
hamsters, rats, and chickens. 
5. Cytotoxicity 
Incubating FB, with mammalian cells in vitro can induce cytotoxicity as evaluated by 
a decrease in cell proliferation or morphologic damage. Yoo et al. (1992) incubated rat renal 
epithelial LLC-PKl cells with 35 fiM FB, (>95% pure) for 72-h resulting in an inhibition of 
LLC-PKl cell proliferation. The FB, was produced by F. moniliforme MRC-826 on SCM. 
After removal from the FB, treatment, the LLC-PKl cells exhibited normal grov^ih kinetics 
and morphology. Therefore, the cytotoxic effect of FB, may have been reversible in these 
LLC-PKl cells. Concentrations of >70 fiM FB, were cytotoxic to the LLC-PKl cells 72-h 
after exposure. Qureshi and Hagler (1992) incubated chicken peritoneal macrophages (PMs) 
with 0.69 |iM FB, (95% pure) for 2-h causing PM cytotoxicity. Morphological damage of 
the PM cells caused by FB, exposure included cytoplasmic blebbing and/or nuclear 
disintegration. Phagocytic potential of PM cells decreased after 4-h of incubation with 27.7 
|iM FB,. There were no increases in FB, cytotoxicity caused by the addition of hepatic 
mixed fimction oxidase (MFO) enzymes to the incubation medium. Furthermore, the 
addition of 55 |aM FB, to the PM culture medium had no effect on the secretion of a cytolytic 
factor after exposure to lipopolysaccharide. Chatteijee et al. (1995) incubated chicken PMs 
with 8.3 |aM FB, for 4-h causing nuclear disintegration in the PMs. The FB, was produced 
by an unidentified flmgi that, based on morphology, may have been F. moniliforme MRC-
826. Fumonisin B|-damaged macrophages could have caused impaired immune functions in 
chickens making them susceptible to diseases. However, FBs were not acted on by chicken 
hepatic MFOs, and FB, did not inhibit the secretion of a cytolytic factor by chicken PMs. 
These data suggested that chickens or turkeys may have had a decreased resistance to 
bacterial infection after consumption of FBs. Gelderblom et al. (1996) incubated male Fisher 
primary rat hepatocytes with 500 |iM FB, (98% pure) for 24-h resulting in inhibition of 
palmitate incorporation into the rat hepatocytes suggesting altered lipid synthesis. The FB, 
induced cytotoxic effects and altered growth responses may have been attributed to fatty acid 
changes in the major membrane phospholipids and altered fatty acid content of the rat 
hepatocytes. These data suggested that FB, may have caused cytotoxicity in rat epithelial 
LLC-PKl, chicken PMs, and rat hepatocyte cells. 
Comparing the cytotoxic effects of FB, and FB, in cell cultures may suggest a 
possible toxicity mechanism based on lipophilicity of these compounds FBs. Cawood et al. 
(1994) incubated primary hepatocytes from male Fisher rats with ['"CJ-FB, or ['''CJ-FB, 
(>95% pure) for 48-h resulting in hepatocyte cytotoxicity. The minimum cytotoxic 
concentrations were 300 |iM for ['''C]-FB, and 150 |iM for ['"CJ-FBi. The FBs were 
produced by F. moniliforme MRC-826 on SCM. Cytotoxicity was correlated with the release 
of LDH fi-om the hepatocytes. The effective dose levels (EDL) [i.e. the lowest level of toxin 
required to elicit a cytotoxic effect] for binding of FBs to hepatocytes were similar at about 
320 lamoles of FB, or FBi/mg protein. There was no indication of metabolism of FB, by the 
rat liver microsomes after incubating them with <600 |iM FB,. Dombrink-Kurtzman et al. 
(1994) incubated turkey lymphocytes with FB, or FB, (both >95% pure) for 72-h inhibiting 
cell proliferation. The FBs were produced by F. proliferatum in SRM. The IC50 for 
inhibition of turkey lymphocytes was 1.9 FB, and 0.6 |iM FB^ suggesting that FB, was 
over 3-fold more cytotoxic than FB, to turkey lymphocyte cells. Cell proliferation was 
evaluated by the MTT bioassay in which the tetrazolium salt, MTT, was reduced to MTT 
formazan by metabolically active cells. These data suggested that FB, exhibited a higher 
cytotoxicity and specific binding to primary rat hepatocytes than FB,. These data are 
consistent with the higher lipophilicity of FB, than FB,, which suggests that FB, is better at 
penetrating cell membranes than FB,. 
The fact that FB, was more lipophilic than FB, and was more toxic to cell cultures 
suggested that the more lipophilic HFBs would be more toxic, on a dietary basis, than their 
respective FBs. In addition, the FAs would be expected to be less toxic than their respective 
FBs based on the blocked amine group which was thought to play a role in cytotoxicity. 
Gelderblom et al. (1993) incubated male primary Fisher rat hepatocytes with FB,, FB,, FB3, 
HFB,, HFB,, FA,, and FAj (all >90% pure) for 48-h resulting in hepatocyte cytotoxicity-. 
Cytotoxicity was correlated to the release of LDH from the hepatocytes into the culture 
medium. Fumonisin Bj had the highest cytotoxicity on a molar basis to the hepatocyte cells 
followed by FBj and then by FB,. The CD50 which caused a 50% release of LDH from the 
hepatocytes for FB, and FB, were 1000 and 2000 |iM, respectively. The cytotoxicities of 
HFB, and HFB, were greater and the cytotoxicities of FA, and FA2 were less dian their 
respective parent compounds (FB, and FB,). There was no cytotoxicity observed in these 
cells when incubated with the TCA groups. Abbas et al. (1993) incubated rat hepatoma 
(H4TG), dog kidney (MDCK), and mouse 3T3 fibroblast (3T3) cells with FB,. FB,. HFB,. 
HFB,, FA], and FA, (all >90% pure) for 24-h. The FBs and FAs were produced by F. 
moniliforme MRC-826 on SCM. The IC50 values for FB, and FB, were 18 and 2 |aM, 
respectively, for H4TG cells and 36 and 20 (iM, respectively, for MDCK cells. The IC,,, 
values for HFB, and HFB, were 5 and 37 |iM, respectively, for H4TG cells, 93 and 20 |iM. 
respectively, for MDCK cells, and 33 and 4.7 |i.M, respectively, for mouse 3T3 cells. There 
was no observed toxicity to3T3 cells incubated with <70 ^iM of FB, or FB,. The FAs were 
not toxic to any of these cell lines at <132 jiM FAs. These data suggest that FB, was more 
toxic to cell cultures than FB, which is consistent with Cawood et al. (1994) and Dombrink-
Kurt2man et al. (1994). The HFBs appear to be equally cytotoxic to their relative FBs when 
incubated with cell cultures at equal concentrations. Detoxification of FBs may require the 
removal or blockage of the free amino group which may be needed for its cancer initiating 
activity. The lack of toxicity of the FAs to rat hepatocytes, H4TG, MDCK, and 3T3 cell 
lines may be due to their blocked amine group which could play a crucial role in the toxicity 
of the FBs and HFBs. The FBs had different cytotoxicities to mammalian cell lines. 
Fumonisin B, was more cytotoxic than FB, to rat hepatocytes, turkey lymphocytes, H4TG, 
MDCK, and 3T3 cells. Furthermore, HFB, was more cytotoxic than FB, in rat hepatocytes 
and 3T3 cells suggesting increased penetration of cells by HFB, than by FBj. This same 
pattern of toxicity and lipophilicity existed between HFB, and FB,. 
Huang et al. (1995) incubated Afncan green monkey kidney (CV-1) cells with 1 |iM 
FB, (>98% pure) for 3-h which caused a 2-fold decrease in PKC expression. At 5 jaM FB,, 
there was a 5-fold AP-1-dependent transcription repression confirming that FB, causes PKC 
repression in CV-1 ceils. The FB, caused a 10-fold stimulation of a simple promotor which 
contained a cyclic AMP response element independent of protein kinase A (PKA). The 
ability for FB, to repress specific PKC isoforms and alter signal transduction pathways may 
play a role in its toxicity towards CV-1 cells. The ability for FB, to decrease PKC expression 
may suggest a role in its ability to cause cancer. 
6. Carcinogenicity 
Previous studies have suggested that carcinogens may cause an increase in GGT-
altered hepatic foci (AHF) in rats (Goldsworthy et al., 1986; Scherere and Emmelot. 1975). 
The induction of cancer by chemical compounds can occur by initiation followed by 
promotion (Emmelot and Scherer 1980; Pitot and Sirica, 1980). A compound that causes 
initiation or promotion is considered a carcinogen. Gelderblom et al. (1993) fed Male Fisher 
rats (150 g BW) 1400 ^moles FBs/kg diet for 21 d followed by 0 [imoles FBs/kg diet for 14 
d. The rats were dosed with 2-acetylaminofIuorene followed by a partial-hepatectomy and 
fed 0 iimoles FBs/kg diet for 14 d. The rats were sacrificed and liver cancer was observed as 
determined by the presence of GGT-AHF. The control rats did not develop liver cancer. The 
FBs were produced by F. moniliforme on SCM. No carcinogenicity was observed in rats 
which consumed 1400 [imoles of FAs, HFBs, or tricarboxylic acid (TCA)/kg diet for 21 d 
followed by the promoting treatment suggesting that the intact FBs are cancer initiators in 
male Fisher rats. These data suggested that FB, may have been a cancer initiator. 
Gelderblom et al. (1988) fed a com diet containing 10.4 [imoles FB,/kg diet for 4 wk 
to male BD-IX rats (150 g BW) that have been initiated for liver cancer with DEN resulting 
in elevated numbers of GGT-(+) altered hepatic foci (AHF) relative to that of rats which 
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received only the DEN-initiation treatments. The FB, was produced by F. moniliforme 
MRC-826 on SCM. Cancer and toxic effects (decreased BW and hepatitis) were evident in 
the FB, treated rats. Hendrich et al. (1993) fed a com diet containing 69 (imole FB,/kg diet 
to DEN-initiated male Fisher rats causing an increase in plasma glutamate-pyruvate 
transaminase and hyperplastic liver nodules. Lebepe-Mazur et al. (1995) fed a com diet 
containing 27 |imoIes FB,/kg diet for 6 months to female DEN-initiated Sprague-Dawley rats 
(6 wk old) resulting in an increased nimiber of placental glutathione S-transferase (+)-AHF. 
The FB, was prepared from F. proliferatum M-5991 grown on SCM. These data suggested 
that FB, was a cancer promoter to male and female rats in these experiments. 
Voss et al. (1993) fed 69 iimoles FB, (>99% pure)/kg diet for 4 wk to non-initiated 
male and female Sprague-Dawley rats (4 wk old) resulting in liver and kidney cancer in the 
rats. The FB, was produced by F. moniliforme MRC-826 on SCM. All rats developed 
microscopic liver lesions characterized by scattered focal (single cell) hepatocellular necrosis 
and hepatocellular cytoplasmic vacuolation which appeared more advanced in females. No 
differences in behavior, food consumption, or BW were observed in any of the rats. Cortical 
nephrosis was found in male rats fed 21 jimoles FB,/kg diet and in female rats fed 69 lamoles 
FB,/kg diet. Relative kidney weights were decreased in male rats but not female rats fed 69 
jimoles FB,/kg diet compared to controls. Hepatic and renal lesions were observed. Both 
male and female rats developed liver cancer after they consumed >69 jamoles FB,/kg diet. 
However, the kidneys of male rats were more sensitive to than female rats to FB,. 
These data suggested that male rats were 3-fold more sensitive than female rats to FB, 
induced kidney cancer but equally sensitive to FB, induced liver cancer. 
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7. Atherosclerotic effects of FBs 
Vervet monkeys (1.4 y, 1.76 kg BW) were fed com containing 2.5 fimoles FBs/kg 
BW/d for 4.5 yr which induced indicators of atherosclerosis such as plasma fibrinogen and 
blood coagulation factor VII (Fincham et al., 1992). The FBs were produced by F. 
moniliforme MRC-826 on SCM. In addition, there was an elevation in plasma low density 
lipoprotein-C and apoIipoprotein-B in these primates suggesting that symptoms of 
atherosclerosis may have been caused by FBs. Smith et al. (1996) fed a com diet containing 
50 famoles HFB,/kg BW/d for 7 d to male castrated cross-bred pigs (40 kg BW) resulting in 
cardiovascular disease in the pigs. Symptoms of cardiovascular disease caused by HFB, in 
the pigs included decreases in maximal rate of change of left ventricular pressure, heart rate, 
cardiac output, mean aortic pressure, arterial and mixed venous blood tension, and 
systemic delivery. Other cardiovascular symptoms caused by HFB, in the pigs included 
increases in mean pulmonary artery pressure, pulmonary vascular resistance. 0, 
consumption, and 0, extraction ratio. These data suggested that low levels of FBs may have 
increased the risk of secondary vascular disease in primates. Also, HFB, induced left-sided 
heart failure in swine. 
I. Bioavailability of Fumonisin in Rats 
The measure of a compound's bioavailability includes administering the compound in 
an animal model and quantification of that compoimd in excreted material or in tissues. 
Bioavailability of FBs in rats is an estimate of the dose exposure these compounds have in 
the animals which is affected by absorption, excretion, and accumulation. Absorption of an 
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oral dose is hindered by the GI tract barrier. Analysis of FBs in biological tissues is difficult. 
Furthermore, enzymatic degradation of FBs could result in decreased FB recoveries using 
HPLC-fluorometric analysis. However, there have been no reports of enzymatic degradation 
of FBs. 
Amounts of unmetabolized FB, in the urine and feces of rats dosed by gavage with 
FB, were quantified by HPLC fluorometric analysis of the OPA-FB, derivative. Shephard el 
al. (1992a) administered 10.4 jamoles of FB,/kg BW to fed male BD-IX rats (150 g BW) by 
gavage and observed 0.4% of the FB, dose was excreted in the urine after 48-h. Hopmans et 
al. (1997) gavaged fed male Fisher rats (9-10 wk old, 160-190 g BW) with 0.69, 6.93. or 69.3 
Hmoles of FB, (70% pure)/kg BW and observed 110, 92, and 98% of the dose, respectively, 
was excreted in the feces and 7.4, 1.2, and 0.5% of the dose, respectively, was excreted in the 
urine over 96-h after dosing. The combined data of the three FB, levels suggested that FB, 
was excreted nearly completely in the feces (101%) with only a small part in the urine (2.7%) 
of the rats after 96-h. However, increasing the FB, dose decreased the percentage of the total 
dose that was recovered in the urine suggesting that at a higher FB, dose, a lesser percentage 
of total dose was absorbed or a greater percentage of total dose was excreted though bile of 
these rats. These data suggested that FB, administered by gavage was eliminated in the urine 
at 7% of the 0.69 {imoles of FB,/kg BW dose in fed male Fisher rats. However, only 0.4% of 
the 10.4 fimoles of FB,/kg BW dose was excreted in the urine of fed male BD-IX rats 
(Shephard et al., 1992a) and 1.2% of the 6.9 iimoles of FB,/kg BW dose recovered in the 
urine of the Hopmans's et al. (1997) male Fisher rats. 
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Similar to the gavage treatments, biological tissues of rats dosed intraperitoneally 
were quantified using HPLC-fluorometric analysis. Shephard et al. (1992a) administered 
10.4 fimoles of FB,/kg BW to fed male BD-IX rats (150 g BW) intraperitoneally. The FB, 
was rapidly absorbed into the blood reaching a maximum concentration of 12 nmoles/ml in 
plasma of the rats after 20 min. The FB, had a relatively short plasma half life of 18 min 
after dosing. Only 16% of the dose was eliminated unmetabolized in the urine of the rats 24-
h after dosing. These data suggested that urinary excretion was a major route for elimination 
of FB| by rats. 
Scintillation counting of radioactive ['""Cl-FB allows for improved detection of FBs in 
biological tissues over HPLC-fluorescence methods. Fumonisin B, has been radioactively 
labeled when ['"CJ-acetate or ['•'C]-methionine were added to cultures of F. moniliforme or F. 
proliferatum in LM. Norred et al. (1993) dosed fasted male Sprague-Dawley rats (150-200 g 
BW) by gavage with 1.4 [imoles of ['''C]-FB,/rat. The rats excreted 80% of the ['"^Cl-dose in 
the feces 48-h after dosing. Within 96-h after dosing, 2-3% of the ['•'C]-dose was excreted in 
the urine, while the liver accumulated a maximum of 0.5% of the ['•'C]-dose 4-h after dosing. 
The blood and kidneys retained 0.2 and 0.1% of the ['•'C]-dose 96-h after dosing. Shephard 
et al. (1992b) dosed fed male BD-IX rats (6 wk old, 150 g BW) by gavage with 10.4 ^moles 
of ['"CJ-FBi (96% pure)/kg BW. All of the ['''C] was recovered in the feces and trace 
amounts were found in the urine, liver, kidneys, and blood after 24-h. Shephard et al. 
(1994a) cannulated and dosed by gavage fed male Wistar rats (6-8 months old, 350-400 g 
BW) with 10.4 ^xmoles of ['"CJ-FB, (93% pure)/kg BW. The rats excreted 0.2% of the ['''C] 
dose in the bile within 24-h. Comparing fasted Sprague-Dawley rats gavaged with 6.9 
jimoles of ['''C]-FB,/kg BW (Norred et al., 1993) to fed Fisher rats gavaged with 6.9 i^moles 
of FB,/kg BW (Hopmans et al., 1997), the fasted rats absorbed and excreted in the urine 2-
fold more FB, than fed rats. However, biliary excretion of FB, may have been responsible 
for excretion of 0.2% of the dose in both studies. In addition, scintillation counting of ['•*€]-
FB, may have quantified metabolized and unmetabolized FB, (Norred et al., 1993). while the 
fluorometric analysis of FB, only quantified immetabolized FB, (Hopmans et al., 1996). 
Norred et al. (1993) administered 6.2 nmoles of ['•'C]-FB,/rat to fasted male Sprague-
Dawley rats (150-200 g BW) by iv. The ['''C]-FB, dose was equivalent to 0.03 lamoles of 
['''C]-FB,/kg BW for a 200 g rat and produced 10,000 decays per min (dpm). The rats 
excreted 35 and 10% of the [''*C]-dose in the feces and urine, respectively, and 30. 10, and 
2% of the ['''C]-dose was recovered in the liver, kidneys, and GI tract, respectively, after 96-
h. Shephard et al. (1992b) dosed fed male BD-IX rats (6 wk old, 150 g BW) 
intraperitoneally with 10.4 jimoles of ['''C]-FB, (96% pure)/kg BW. The ['^C]-FB, dose 
produced 100,000 dpm/rat. The rats excreted 66% of the ['''C] in the feces and 32% in the 
urine 24-h after dosing. Trace amounts of ['"C] were recovered in the liver, kidneys, and 
blood 24-h after dosing. Shephard et al. (1994a) dosed bile duct cannulated male Wistar fed 
rats (6-8 months old, 350-400 g BW) intraperitoneally with 10.4 ^moles of ['•*C]-FB, (93% 
pure)/kg BW. The rats dosed intraperitoneally eliminated 67% of the ['"'C] dose in the bile 
within 24-h after dosing. These data suggested biliary excretion was a major route of 
elimination of ['''C]-FB, dosed in these rats. Over half of the absorbed dose of FB, was 
excreted in the bile indicating that FB, dosed by gavage to rats may have been absorbed by 
the GI tract to a greater extent than previously reported. 
The bioavailability of compounds similar to FB,, such as HFB, and FB,-FRU. in rats 
has recently been reported. Amounts of unmetabolized HFB, and FB,-FRU in urine and 
feces of fed rats were hydrolyzed and quantified for their OPA-HFB, derivatives by HPLC 
fluorometry. Hopmans et al. (1997) gavaged male Fisher fed rats (9-10 wk old. 160-190 g 
BW) with 0.69, 6.93, or 69.3 jimoles HFB, (70% pure)/kg BW and observed 15.1. 1.3. and 
0.2% of the total dose, respectively, was excreted in the urine. Similarly, fed rats gavaged 
with 0.69 or 6.93 [amoles FB,-FRU/kg BW excreted 9.8 and 0.8% of the total dose in the 
urine, respectively. Increasing the HFB, or FB,-FRU dose decreased the percentage of the 
doses that were recovered in the urine. Similar to the FB, treatments by Hopmans et al. 
(1997), increasing the HFB, or FB,-FRU dose decreased the percentage of the total dose that 
was recovered in the urine suggesting that at a higher HFB, or FB,-FRU dose, a lesser 
percentage of total dose was absorbed or a greater percentage of total dose was excreted 
though bile of these rats. These data suggested that absorption of 0.69 (imoles of FEFB, or 
FB,-FRU occurred in these rats dosed by gavage and was eliminated in the urine at 15.1 and 
9.8% of the total dose, respectively. Biliary excretion may have been responsible for some of 
the elimination of these compoimds from the rats as suggested by biliary excretion of ['"'C]-
FB, by Shephard et al. (1994a). If biliary excretion of HFB, and FB,-FRU occiarred to a 
lesser extent than FB,, then this might explain why higher percentages of HFB, and FB,-FRU 
relative to FB, were eliminated in the urine of these rats. 
Fumonisin B„ HFB,, and FB,-FRU are absorbed by the GI tract of rats. With respect 
to FB,, less than 5% of a gavaged dose is absorbed and excreted in the urine or accumulated 
in the tissues. However, biliary excretion of FB, is only slightly occurring suggesting that 
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the absorption of FB, is only slightly greater than the amount excreted in the urine. Gavaging 
unfed rats appears to increase the absorption of FB,. However, a study of similar rats and at 
the same doses which could measure this has not been reported. 
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CHAPTER 3. FUMONISIN B, PRODUCTION BY FUSARIUMPROLIFERATUM 
STRAIN M599I IN A MODIFIED MYRO LIQUID MEDIUM 
A paper published in the Journal of Natural Toxins' 
William R. Dantzer^-', Anthony L. Pometto HI", and Patricia A. Murphy-"* 
Abstract 
Fusarium proliferatum strain M5991 cultures were grown in shake flasks containing 
modified Myro (MM) medium (MgS04 reduced to 0.5 g/L) plus 0.0.25. 0.50. 0.75. 1.00. or 
1.25% (v/v) hot-water com-hull-extract (CHE) for 69 days. After 4 days of incubation, shake 
flask liquid cultures with 0.75, 1.00, and 1.25% (v/v) CHE showed a reduction in pH from 
6.0 to 2.6 and consumed sucrose at >6.3 g/L/d. After 69 days of incubation, the same shake 
flask cultures produced over 7.8 g/L cell mass and over 990 mg/L ftimonisin B, (FB,). A 
minimum CHE level of 0.75% was recommended for enhanced FB, production by F. 
proliferatum strain M5991. During three serial (10, 12, and 12-L) batch fermentations in 
MM medium + 1.00% (v/v) CHE (first batch only), F. proliferatum strain M5991 produced 
FB| concentrations of 619, 659, and 375 mg/L after 35. 47, and 52 days of incubation, 
respectively. By analysis, a total yield of 20 g FB, was obtained from three serial batch 
fermentations. 
Key words: Liquid Fermentation, Com Hull Extract, Maize Pathogen, FB„ Fungus 
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Introduction 
The fumonisins (FBs) are a family of mycotoxins including FB,, FB,. FB,, and FB^ 
(Wilkes et al., 1995; Beier et al., 1995) with FB, the most predominant. Fumonisins are 
produced by the maize pathogens, Fusarium proliferatum and Fusarium moniliforme. The 
fumonisins cause various toxic symptoms in different animal species. 
Leucoencephalomalacia (LEM) was induced in a male horse after 20 doses containing 1 to 4 
mg of 95% pure FB,/kg diet (total dose 8.4 g FB,) for 29 days (Kellerman et al, 1990). Five 
ponies developed LEM after feeding on diets containing 8 mg FB,/kg diet for 180 days 
(Wilson et. al., 1992). Pulmonary edema was induced in weanling pigs fed 92 mg FB,/kg 
diet (Osweiler et al., 1992) and in 16-24 kg pigs fed com screening diets containing 155 mg 
FB|/kg diet for 7 days (Colvin and Harison 1992). Embryopathenicity was induced in 
chicken embryos when eggs were inoculated with 72 ng FB, per egg (Javed et al., 1993). 
Developmental toxicity was observed in hamsters dosed by gavage with >6 mg FB|/kg diet 
(Floss et al., 1994). Liver cancer occurred in rats fed a 50 mg pure FB|/kg diet for 26 months 
(Gelderblom et al., 1991). Renal lesions developed in male rats fed 15 mg of a 99% pure 
FB,/kg diet for 4 weeks (Voss et. al., 1993). In contrast, FBs appeared to be only slightly 
toxic to calves fed 148 mg total FBs/kg diet (Osweiler et al., 1992). The effects of FBs on 
human health are not known, but human esophageal cancer may be associated with FB 
consumption (Chu and Li, 1994). FB, has been declared a class 2B carcinogen (lARC. 
1993). 
The purified FB, used in most of the previous studies cited has been isolated from 
solid com culture fermentations of either F. moniliforme or F. proliferatum. Liquid-culture 
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fermentations alleviate some purification problems caused by impurities derived fi-om solid-
state fermentations of F. proliferatum on com or rice which co-purify with FB, (Miller et ai. 
1994). 
Preliminary data illustrated that growth and fimionisin production of F. proliferatum 
strain M5991 were enhanced by the addition of 10 ml Com-hull-extract (CHE) to 1-L 
modified Myro (MM) medium. In this paper, we report significantly enhanced cell growth 
and FB| production by F. proliferatum strain M5991 through the addition of a hot-water 
CHE in shake flask cultures and in a 10-L repeated batch fermentation. 
Materials and Methods 
Liquid media 
Myro (M) medium consisted of 1.0 g (NH4)2HP04 (Fisher Scientific, Fair Lawn, N. 
J.). 3.0 g KH2PO4 (Fisher), 2.0 g MgS04 • THiO (Baker Chemical Co., Phillipsburg, N.J.), 
5.0 g NaCl (Fisher), 40 g sucrose (Fisher), and 10 g glycerin (Fisher) in 1-L distilled-water 
(dHjO); pH 5.9 (Chelkowski, 1989). Modified Myro (MM) medium consisted of M medium 
reduced to 0.5 g/L MgS04 • THiO. Reduced sucrose modified Myro (RSMM) medium 
consisted of MM medium reduced to 20 g/L sucrose. 
Corn-hull extract (CHE) was prepared by autoclaving 10 g of com hulls (crude com 
fiber, Penford Product Cora, Cedar Rapids, lA) with 100 ml of dHjO for one hour 12rC 
followed by centrifugation at 13,776 x g for 10 minutes. The clarified CHE was made to 100 
ml volume using dHjO, sterilized at I2rc for 20 minutes, and stored at ambient temperature 
until needed. 
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Fungal culture 
Lyophilized fungal spores of F. proliferatum strain M5991, a predominant FB, 
fiimonisin-producing isolate, were obtained from Dr. Paul Nelson (Pennsylvania State 
University, University Park, PA). The fungal spores were rehydrated in capped 1 -L baffled 
Erienmeyer flasks containing 500 ml of sterile RSMM medium. The rehydration flasks were 
incubated for 7 days at ambient temperature on a New Brunswick GIO rotary shaker (New 
Brunswick Scientific Co., Inc. Edison, NJ) at 220 rpm (2.5 cm throw) and the cells were 
collected by centrifugation at 8,671 x g for 10 minutes . The fungal cells were stored as 
followed using the method of Windels et al. (1988). The concentrated fungal cells were 
resuspended in 100 ml of sterile 10% skim milk broth (Shoppers Value Instant nonfat dry 
milk. Preferred Products Inc., Eden Prairie, MN). Aliquots (0.5 mL) containing the 
resuspended fungal cells were added drop-wise to 19 x 150 mm screw-capped tubes 
containing 15 g of sterile silica gel beads (grade 40, 6-12 mesh) (Aldrich Chemical Co.. 
Milwaukee, WI), shaken, and stored at 4°C until needed. 
Inoculum was prepared by transferring 10 to 20 of the fiingal-containing silica beads 
into a 1-L baffled Erienmeyer flask containing 500 ml of sterile MM medium plus 1% (v/v) 
CHE and incubating for 4 days at ambient temperature with shaking at 220 rpm. These 
conditions yielded 5x10^ CFU/mL in logarithmic phase. 
Shake flask cultures 
Cultures (5 ml inoculimi) were grown in 1-L Erienmeyer flasks containing 500 ml of 
MM medium plus 0.00, 0.25, 0.50, 0.75,1.00, or 1.25% (v/v) CHE. Incubation was at 
ambient temperature with shaking at 220 rpm (2.5 cm throw) for 69 days. Samples (5 mL) 
were removed weekly, filtered through a 0.45 fim (25 mm diameter) filter (Micron 
Separations Inc., Westboro, MA), and stored at -20°C until analyzed. Cultures were grown in 
triplicate, and 10 samples fi-om each culture were obtained. 
Fermentor conditions 
Batch fermentation I 
The fermentor vessel (15-L New Brunswick microferm fermentor vessel. New 
Brunswick Scientific Co., Inc. Edison, NJ), containing sterilized MM medium (9.8-L) and 
CHE (0.1-L) was inoculated with the previously described inoculum (0.1-L) and maintained 
at 28°C with 220 rpm agitation. Filter sterilized (0.2 |im) air was pumped into the culture 
medium at 2.1 wm. Foam was controlled by an automatic antifoam controller with antifoam 
FM (Hodag Corp., Skokie, IL). Samples were taken every 12 hours for 3.5 days and then 
weekly throughout the fermentation. After 35 days of incubation, the agitation was 
terminated for 24 hours and the cell mass allowed to settle. Culture filtrate (7-L) was 
pumped out via a "J" tube leaving about 2-L of residual cell mass and culture filtrate in the 
fermentor vessel. The harvested culture filtrate was stored at 5°C until analyzed for FB,. 
Batch fermentation 2 
The fermentor, containing residual cell mass and culture filtrate, was refilled 
aseptically to a total 12-L with sterile MM medium. Samples were taken weekly throughout 
the fermentation. After 47 days of incubation, the agitation was terminated for 12 hours and 
the cell mass allowed to settle. Culture filtrate (7-L) was pumped out via a "J" tube leaving 
about 4-L of residual cell mass and culture filtrate in the fermentor vessel. The harvested 
culture filtrate was stored at 5°C until analyzed for FB,. 
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Batch fermentation 3 
The fermentation proceeded as described in batch fermentation 2. After 52 days of 
incubation, all of the residual cell mass and culture filtrate (11-L) were collected from the 
fermentor vessel and stored at 5°C vmtil analyzed for FB,. 
Each serial batch fermentation lost about 0.9-L dHiO due to evaporation and an 
additional 0.1-L of culture filtrate was removed during sampling. 
Fungal growth analysis 
pH 
The pH of liquid culture samples from shake flasks and fermentation batches 2 and 3 
were measured using a Coming Model 12 research pH meter. The pH from batch 
fermentation 1 medium was measured in the fermentor vessel using an Ingold sterilizable pH 
electrode. 
Reducing sugars 
Total reducing sugars were quantified by Somogyi-Nelson method (Somogyi, 1945; 
Nelson 1944). Samples containing < 120 |ig reducing sugar were prepared by transferring 1 
ml of sample into 10 ml volimietric flasks containing 5 ml of HCl (6 N), mixing, and 
allowing to stand at room temperature for 24 hours. The pH was adjusted to 7 with NaOH 
(10 N), filled to volume (10 mL) with dH^O then mixed. The samples were analyzed for 
absorbance at 520 nm and compared to a hydrolyzed sucrose standard curve. 
Cell density 
Cell densities were determined by filtering measured volumes (2-5 mL) of liquid 
culture samples through a preweighed 0.45 nm (25 mm diameter) filter (Micron Separations 
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Inc., Westboro, MA). Cells were dried at 60°C for 24 hours, equilibrated to room 
temperature, then weighed. 
Fumonisin analysis 
Fumonisin B, concentrations were measured according to the procedure of Hopmans 
and Murphy (1993). Aliquots (100 ^1) containing 0.45 |im filtered fermentation medium 
were derivatized for 10 minutes with 100 |al o-phthaldialdehyde (OP A) solution (5 mg OP A. 
5 ml acetonitrile, and 10 |al 2-mercaptoethanol), 100 nl buffer (0.05 M K2HPO4 pH adjusted 
to 8.3 with 0.05 M KH2PO4), and 100 nl dHiO. The derivatized samples were diluted with 
100 |il of dHiO and injected (20 nl) into a high performance liquid chromatography (HPLC), 
(Beckman Instruments, Fullerton CA) with analytical reverse phase C,8 column (Perkin and 
Elmer Corp., Norwalk, CT) (3niin ID, and 4.6 cm length). The mobile phase was 40% 
acetonitrile and 60% 0.05 M KH2PO4 (pH adjusted to 3.3 with concentrated phosphoric acid) 
at a flow rate of 1.5 ml per minute. The FB, fluorescent derivatives were quantified using a 
Turner fluorometer (Coming 7-60 primary filter and Wratten 2a secondary filter, 15 fA flov\<-
cell) and compared against a FB, standard generously donated by P.O. Thiel of the Research 
Institute for Nutritional Diseases, South AMcan Medical Research Council, South Afnca. 
CHE analysis 
A 10-ml preweighed sample of CHE was evaporated in a weighed cmcible over a 
Bunsen burner flame followed by heating in a muffled furnace at lOOCC for 8 hours. The 
ashed sample was analyzed for calcium (Ca), potassium (K), magnesium (Mg), sodium (Na), 
phosphorous (P), and zinc (Zn) by inductively coupled plasma-atomic emission (ICP-AE) 
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spectroscopy (Fisons, 3410 ICP with minitorch, Beverly MA.) (Analytical Services Division 
of Ames Laboratory, United States Dept. of Energy, Iowa State University, Ames lA). 
Statistical analysis 
The experimental design for the CHE study consisted of six treatments: 0.00. 0.25. 
0.50,0.75, 1.00, and 1.25% (v/v) CHE. Each treatment was replicated in three different 
flasks. Data were analyzed using ANOVA least significant difference (LSD) Test for 
variable: Y (model y = treatment, n = 3) on SAS system v. 6.07 (Cary, NC) (p < 0.05). 
Results and Discussion 
Corn hull extract 
The enhancement of cell growth and FB, production by F. proliferatum strain M5991 
by the addition of CHE was discovered while investigating surface attachment abilities of the 
mold to plastic composite supports (40% of either oat, soy, barley, or com hulls; 10% yeast 
extract; and 50% polypropylene; Demirci et al. [1993]). The CHE used in this study was 
made from 10 g wet-milled com hulls per 0.1-L of dH,© and contained 47.0 g dissolved 
soIids/L (3.9 g ash/L). The ICP-AE-analyzed CHE contained: Ca (0.02 g/L), K (1 g/L), Mg 
(0.3 g/L), Na (0.06 g/L), P (0.71 g/L), and Zn (0.01 g/L). 
Shake flask liquid culture study 
The culture pH reduction could not be attributed to lactic, acetic, or propionic acid 
production as determined by HPLC (Demirci et ai, 1993). However, there were two 
unidentified chromatographic peaks observed by refractive index detection. The pH of the 
culture medium decreased quickest in the treatments containing the highest levels of CHE 
(Fig. 1). The shake flask cultures containing the two highest levels of CHE (1.00 and 1.25%) 
consumed all of the sucrose in the shortest incubation time (32 d) (Fig. 2A). The cell mass 
production plateaued at 32 days incubation for the 0.75, 1.00, and 1.25% CHE media (Fig. 
2B). The FB, concentration plateaued after 32 days of incubation in the 1.00 and 1.25% 
CHE media, after 48 days in the 0.50 and 0.75% CHE media, and was still increasing after 69 
days of incubation in the 0.00 and 0.25% CHE media (Fig. 2C). Negligible amounts of FB, 
and FBj were detected in media of F. proliferatum M5991. 
The rate of pH change for all treatments was evaluated between 0 and 2 days because 
the pH of the 1.25% CHE treatment plateaued after 2 days of incubation (Fig. 1). The rate of 
reducing sugar and cell density change were evaluated between 0 and 4 days of incubation 
and represented initial rates (Fig. 2A,B). Rates of pH drop after 2 days of incubation and 
rates of cell mass production after 4 days of incubation with F. proliferatum strain M5991 
were significantly greater in the culture media containing 0.50, 0.75, 1.00, and 1.25% CHE 
than the culture medium containing no CHE (p < 0.05) (Fig.s 1 and 2B). The rate of 
reducing sugar consumption after 4 days of incubation was significantly greater in the culture 
media containing 0.75,1.00, and 1.25% CHE than the culture medium containing no CHE (p 
< 0.05) (Fig. 2A). 
The 21 days incubation time, in which reducing sugar, cell density, and FB, 
concentrations were evaluated, represented the incubation time in which the FB, culture 
medium containing 1.25% CHE plateaued (Fig. 2A-C). The reducing sugar, cell density, and 
FB| concentrations were significantly greater in the culture media containing 0.50, 0.75, 1.00, 
and 1.25% CHE than the culture medium containing no CHE after 21 days of incubation (p < 
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0.05). The cell density and FB, concentrations evaluated after 69 days of incubation 
represented the final experimental values (Fig. 2B,C). The cell densit>' and FB, 
concentrations were significantly greater in the culture media containing 0.50. 0.75, 1.00. and 
1.25% CHE than the culture mediimi containing no CHE after 69 days of incubation (p < 
0.05). However, FB, concentrations were not significantly different from the culture media 
containing 0.75, 1.00, or 1.25% CHE after 69 days of incubation. These latter CHE 
concentrations suggest that the minimum concentration of CHE which was required for 
optimum production of FB, by F. proliferatum is 0.75%. 
These data are consistent with those of Blackwell et al. (1994), who found that, under 
similar conditions, a higher inoculum of F. moniliforme strain NRRL 13616 resulted in 
increased amounts of total ftunonisins produced. 
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Figure 1. pH response from Fusarium proliferatum grown in shake flask cultures. Shake 
flask cultures of F. proliferatum strain M5991 inoculated into modified Myro medium 
containmg 0.00 (O), 0.25 (•), 0.50 (A), 0.75 (T), LOO (•), or 1.25 (•) % (v/v) com-hull-
extract. Flasks were incubated at 220 rpm and ambient temperature. Data points represent 
means. Error bars represent standard deviations (n = 3). 
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Figure 2. Growth characteristics of Fusarium proliferatum in shake flask cultures. (A) 
Reducing sugar concentration (g/L), (B) cell density (g/L), and (C) FB, concentration (mg/L) 
from shake flask cultures of F. proliferatum strain M5991 inoculated into modified Myro 
medium containing 0.00 (O), 0.25 (•), 0.50 (A), 0.75 (T), 1.00 (•), or 1.25 (•) % (v/v) 
com-hull-extract. Flasks were incubated for 69 d at 220 rpm and ambient temperature. Data 
points represent means. Error bars represent standard deviations (n = 3). 
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Fermentation study 
Batch fermentations produced 25-L of spent flimonisin culture medium in 136 days 
and yielded 20.4 g of crude FB,. Changes in pH, reducing sugars, cell mass, and FB, were 
continuously monitored. The pH drop to 2.9 after 2 days (Fig. 3) of incubation diuing each 
batch fermentation was similar to the pH drop observed in the shake flask cultures. 
After compensating for evaporation and subtracting initial starting concentrations 
(Fig. 4-C), the repeated serial-batch-fermentations yielded a maximum FB, production of 
619, 659, and 375 mg/L and a maximum cell mass production of 8.3.4.4, and 3.3 g/L (dry 
weight), respectively. The best production of FB, and cell mass was achieved during the first 
fermentation. In addition, the first batch fermentation may have been terminated too early 
because FB, production and sucrose consumption were still occurring at the time of harvest. 
If the first batch fermentation were to continue to 48 days, the maximum yield of FB, could 
be assumed to reach over 800 mg/L (Fig. 4A). This assumption could lead to the logical 
conclusion that the yield of FB, decreases during the fermentation because the cells were not 
as healthy during the second and third batches as they were during the first batch. Another 
factor that could lead to these results is the fact that CHE was only added to the first batch 
fermentation. 
Foaming was apparently not a problem during the first (10-L) batch fermentation; 
therefore, the volumes of the second and third batch fermentations were increased to 12-L. 
Because there is cell mass and culture filtrate carryover, the second and third serial batch 
fermentations were calculated to have initial FB, concentrations of 113 and 349 mg/L. 
respectively. However, the respective FB, concentrations were found to be 310 and 320 
mg/L. The high measured level of FB, at 0 hour, in the second batch fermentation, was 
probably the result of a sampling error and was omitted from Fig. 4B. 
Miller et al., (1994) reported total flimonisin (FB, + FB,) levels of almost 300 mg/L. 
cell masses of 5.35 g/L. and consumption of all but about 10 g of sucrose after 10 days of 
fermentation in a similar fermentation system with F. moniliforme. In our fermentation with 
F. proliferatum strain M5991, a predominant FB, producer, FB, levels (200 mg/L) and cell 
mass (2 g/L) achieved from our fu^st batch fermentation (Fig. 4A), after 10 days of 
fermentation, were less than those reported by Miller et al., (1994). However, F. 
proliferatum M5991 is preferred for FB, purification in our hands since negligible levels of 
FB, and FB, were produced. The cell mass obtained after 10 days of fermentation in the first 
repeated batch fermentation was about half of that obtained during Miller's fermentation but 
our cell mass continued to increase throughout 35 days of fermentation. 
6.0 FERMENTATION tfl 
5.0 
4J0 
3.0 
J 0 
INCUBATION TIME (days) 
Figure 3. pH response for Fusarium proliferatum from fermentation 1 of the repeated batch 
fermentation. 
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Figure 4. Repeated batch fermentation 1 (A), fermentation 2 (B), and fermentation 3 (C), 
quantified for flimonisin production (mg/L) (•), reducing sugar consumption (g/L) (•), and 
changes in dr>' weight cell-mass (g/L) (A) for Fusarium proliferatum strain M599L Batch 
fermentation 1 contained 10-L of Modified Myro medium plus 1% (v/v) com-hull-extract. 
Batch fermentations 2 and 3 contained 12-L of Modified Myro medium. These data were 
measured prior to compensating for evaporation. 
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Conclusions 
Growth and FB, production by F. proliferatum strain M5991 were about the same 
with 0.75. 1.00, and 1.25% (v/v) CHE additions in MM medium. Therefore, we recommend 
that 0.75% CHE be added to the MM medium for the production of FB, by F. proliferatum 
M5991. Repeated batch fermentation has the advantages over non-repeated batch 
fermentations by decreasing the down time that would be needed for cleaning, reinoculating, 
and initial growth of the culture. 
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CHAPTER 4. PURIFICATION OF FUMONISIN B, FROM LIQUID CULTURES OF 
FUSARIUM PROLIFERA TUM 
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Patricia A. Murphy^''' 
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Abstract 
Fumonisin B, (FB,) was purified fi-om liquid culture medium by adsorption, partition, 
and ion exchange liquid chromatography. Liquid-culture filtrates of Fusarium proliferatum 
strain M5991 grown in modified-Myro medium and containing <750 mg FB,/L were eluted 
from XAD-I6, Cg, DEAE-Sepharose, and C,g resulting in 96-100% pure FB, with a 37% 
recovery. 
Introduction 
Fumonisins (FBs) are a family of mycotoxins (FB,, FB,, FB3, and FB4) which are 
produced by the maize pathogens Fusarium proliferatum and Fusarium moniliforme. 
' Reprinted with permission from Journal of Agriculture and Food Chem., 1996,44, 3730-
3732. Copyright 1997 American Chemical Society. 
" Graduate student, graduate student, undergraduate student, Technician, and Associate 
Professor, respectively. Department of Food Science and Human Nutrition, Iowa State 
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' Primary researcher and author. 
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Purification of FBs has been pursued for the purpose of establishing their acceptable levels in 
foods for human and animal consumption. The FBs have been purified from solid com 
cultures of F. moniliforme strain MRC 826. Gelderblom et al. (1988), and Cawood et al. 
(1991), purified FBs by extraction, solvent partitioning, XAD (adsorption)-!, silica gel 
(adsorption), and C,8 (partition) liquid chromatography (LC). Cawood et al. (1991). obtained 
>90% pure FB, with a 40% recovery. Voss et al. (1993), obtained >99% pure FB, by XAD-2 
and repeated C,g LC steps. Miller et al. (1994), obtained 97% pure FB, (89% recovery) 
produced from liquid cultures of F. moniliforme strain MRC 826 by DEAE-Sephadex (ion 
exchange), silica gel, and gradient C,8 LC. Recently, Meredith et al. (1996), obtained >95% 
pure FB, with a >90% recovery from solid rice cultures of F. moniliforme strain MRC 826 
using C,8 and cyano (partition) LC. In our lab, we have only obtained 85% pure FB, from 
solid com or rice cultures of F. proliferatum strain M5991 by XAD-16, Cg (partition), silica 
gel, and gradient C,g LC. Using liquid cultures of F. proliferatum strain M5991, we have 
achieved a reproducible purification method of obtaining >95% pure FB, with a 37% 
recovery using XAD-16, Cg, DEAE-Sepharose (ion exchange), and C,8 LC. 
Materials and Methods 
The FB, produced from Fusarium cultures is a class 2B carcinogen (IARC, 1993) and 
caution should be taken during its handling. 
Liquid cultures 
Cultures of F. proliferatum strain M5991 were grown in liquid modified-Myro 
medivim containing <1.00% (v/v) com hull extract (CHE) (Dantzer et al., 1996). Modified 
Myro medium consisted of 1.0 g (NH4)3HP04. 3.0 g KH^PO^. 0.5 g MgSO^^TH^O, 5.0 g 
NaCl, 40 g sucrose, and 10 g glycerin in 1-L distilled-water (dHjO); pH 5.9. The CHE was 
prepared by autoclaving 10 g of com hulls with 100 mL of dHjO for one hour at 12rC 
followed by centrifiigation at 13,776 x g for 10 minutes. The clarified CHE was made to 100 
mL volume using dHzO, sterilized at 12rC for 20 minutes, and stored at ambient 
temperature until needed. The cultures produced <750 mg of crude FB,/L. Upon harvest, the 
liquid cultures were centrifliged and passed through a Whatman #1 filter (Whatman 
Laboratory Division, Springfield Mill, Maidstone, Kent) followed by 0.8 and 0.45 |im MSi 
filters (4.5 cm dia, nylon; Micron Separations Inc., Westboro, MA). 
XAD-16 adsorption LC 
A gravity-fed LC column was made with Amberlite nonionic polymeric adsorbent 
XAD-16 (Surface Area: 800 mVg, Ave. Pore Dia.; 100 A, Wet Mesh Size; 20-60; Sigma 
Chemical Co., St. Louis MO) by transferring 1 kg of dry XAD-16 material into a 100 x 7.5 cm 
glass column containing a fiitted glass filter. The XAD-16 was washed with >2-L of 50% 
acetonitrile (ACN), until the eluent was clear, followed by 6-L of dH^O, and allowed to drain to 
the top of the column bed. Filtered liquid cultures containing ^ g of FB, were introduced onto 
the column. The XAD column was washed with 4-L of dHjO and drained completely. The FBs 
were eluted with 4-L of 50% ACN. The XAD column was regenerated with 4-L of dH^O. Eluted 
FB-containing fractions were concentrated by rotary evaporation (RE) to 30 mL (Rotavapor, 
Buchi/Brinkman Instruments Inc., Westbury, New York) at 50°C and filtered through a 0.45 
|im MSi filter. The FB-containing filtrates were adjusted to a pH of <3.3 using 6 M 
hydrochloric acid (HCl). 
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Cg partition LC 
The Cg mobile phase solutions contained 0.1% (v/v) trifluoroacetic acid. The column 
pressure was maintained at 80 psi throughout. The low pressure Cg LC column (Lobar C8. 
LiChroprep RP-8,40-63 |am. Size B; 310-25; EM Separations, Gibbstown, NJ) was 
conditioned by pumping 500 mL each of ACN and dH,0 through the column with a metering 
pump (LDC Analytical miniPump Model 396, Rainin Instruments Co. Inc., Wobum, MA). 
The pH-adjusted filtrates were partitioned to contain <0.5 g FB, and introduced onto the 
column via 1-3 injections (10 mL of filtrate per injection) with a Rheodyne injection valve 
(Model 7010, Rheodyne Inc., Cotati, CA) and an inline 10 mL injection loop. The column 
was washed with 250 mL each of dHjO and 20% ACN followed by 150 mL of 25% ACN. The 
FB| was eluted with 400 mL of 30% ACN into 12.5 x 1.5 cm tubes (10 mL of eluent/tube) 
using a fraction collector (FRAC-100, Pharmacia Fine Chemicals, Piscataway, New Jersey). 
The eluents were monitored for FB, by thin layer chromatography (TLC), concentrated by RE to 
10 mL, filtered through a 0.45 jxm MSi filter, and pH adjusted to 6.5 using 10 N sodium 
hydroxide (NaOH). The remaining FBs and other contaminants were eluted from the column 
with 100 mL of ACN. The column was regenerated with ^50 mL dH^O. 
DEAE-Sepharose ion exchange LC 
All of the ammonium acetate (NH4-0ac) solutions were pH adjusted to 6.5 using 10 N 
NaOH. Initially, DEAE-Sepharose (65 mL) CL-6B (wet bead size; 45-165 |im, Sigma) was 
washed with 650 mL of milli-Q HjO (MqHjO), resuspended in 1.0 MNH4-0Ac:ACN [1:1], 
and stored at 5''C for 2 d with several resuspensions per day. The DEAE-Sepharose was washed 
with MqHjO until no NH4-OAC odor remained, degassed in 50% ACN, transfen^d into a 30 x 2 
cm column, and allowed to settle by gravity. The column was washed with 200 mL of 50% ACNf 
and drained to the top of the bed. 
The FB,-containing fractions were partitioned to contain <0.5 g FB, and transferred to 
the DEAE-Sepharose column. The sample was allowed to filter onto the column to the top of the 
bed followed by 10 mL of 50% AQvf, which was allowed to drain to the top of the bed. The 
column was washed with 90 mL of 50% ACN followed by 100 mL each of 100 and 200 mM 
NH4-0Ac:ACN [1:1]. The FB, was eluted with 100 mL each of300 and 400 mM NH4-
OAc:ACN [1:1]. The DEAE-Sepharose were regenerated with 100mLof500mMNH4-
OAc: ACN [1:1] followed by 200 mL of 50% ACN. The eluents were monitored for FB, by TLC. 
concentrated by RE to 10 mL, filtered through a 0.45 fxm MSi filter, and pH adjusted to ^.3 
using 6 N HCl. 
C, g  partition LC 
The C,8 LC mobile phase solution contained 0.1 % acetic acid and was pumped at a 
flow rate of 2 mL/min throughout. The YMC-Pack semi-preparatory C,g high performance 
liquid chromatography (HPLC) colunm (AM 323-5, Size: 25 x 1 cm I.D., Particle: S-5 |im, 
120A; YMC Inc., Wihnington, NC) was washed with 60 mL of ACN followed by 60 mL of 
MqHiO. After MqHjO equilibration, the FB,-containing fi-actions were loaded onto the 
column by two injections (5 mL each) with a Rheodyne injection valve (Model 7010) and an 
in-line 5 mL injection loop. The column was washed with 60 mL each of 0, 20, and 25% 
ACN, respectively. The FB, was eluted with 60 mL each of 30 and 35% ACN into 12.5 x 1.5 
cm tubes (10 mL of eluent/tube) using a fraction collector (Pharmacia Fine Chemicals). The 
collected eluents were monitored for FB, by TLC. Eluents containing FB, were concentrated by 
84 
RE to 10 mL at 50°C and filtered through a 0.45 |im MSi filter. The column was 
reconditioned by washing with 60 mL each of 40, 100, and 0% ACN, respectively. 
TLC 
All LC fractions were evaluated for FBs by TLC (Rottinghouse et al., 1992). 
Fractions containing FB, were identified by observing the fluorescence of the FB,-
fluorescamine compound under UV light. 
Freeze drying 
Filtered FB, containing eluents were concentrated by RE, resuspended in 10-15 mL 
MqHjO, and lyophilized in a freeze dryer (18 port, Labconco Corp., Kansas City, MO) for 
>12 hours. 
Fumonisin analysis 
Concentrations of FB, were estimated by HPLC o-pthaldialdehyde (OPA) 
fluorometry (Hopmans and Murphy 1993). Purity of FB, was determined by comparing the 
freeze-dried weight of a purified FB, culture sample to the HPLC-OPA quantified amount. 
The FB, standard curve was prepared with FB, generously donated by P.O. Thiel (Research 
Institute for Nutritional Diseases, South Afncan Medical Research Council, South Afnca). 
For independent confirmation of purity, sample 84 was analyzed using HPLC-OPA 
fluorometry and electrospray mass spectrometry (MS) by Dr. Ronald Platmer (National 
Center for Agricultural Utilization Research, Peoria, IL). 
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Results and Discussion 
The results of nine representative liquid cultures are presented in Table 1. An average 
FB, purity of 102% with a 37% recovery was obtained. There were no differences in FB, 
purity or recovery from the liquid cultures containing different levels of CHE. A purification 
flow chart is presented in Figure 1. The crude FB, in the liquid cultures had a purity of 1%. 
The post-XAD-16 FB, purity was >50%. 
Table 1. Purity data of fumonisin B, containing samples. Fumonisin B, (FB,) mass (mg), 
recovery (%), and purity (%) obtained from liquid cultures of Fusarium proliferatum strain 
M5991 by XAD-16, Cg, DEAE-Sepharose, and C,g liquid chromatography. 
CULTURE 
SAMPLE 
CHE 
(%) 
CRUDE 
FB, 
(mg) 
PURE 
FB, 
(mg) 
FB, 
RECOVERY 
(%) 
FB, 
PURITY 
(%) 
61 0.00 400 267 67 101 
62 0.00 640 169 27 98 
64 0.00 522 287 55 109 
75 1.00 600 379 63 101 
83 0.75 600 151 25 98 
84 0.50 280 82 30 102 
106 1.00 750 126 17 101 
117 0.00 87.5 57 66 100 
120 1.00 480 92 19 96 
TOTAL 4360 1612 37 102 
Liquid cultures were incubated in Myro medium containing 0-1.00% (v/v) com hull extract 
(CHE) for >50 d at 22.5 ±2.5°C. 
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During the Cg LC, FB, was eluted with 30% ACN; however, we observed FB, elution durirrg 
the 25% ACN wash. Therefore, we decreased the volume of this wash from 250 to 150 mL. 
We limited the loading of FB, onto our XAD-16 and Cg columns to 2 and 0.5 g, respectively. 
These mass limits of FB, did not cause overloading of the columns by FBs or contaminants. 
Previously, we obtained >95% pure FB, by repeated DEAE-Sepharose and C,8 LC. The 
average recovery of FB, (37%) in Table 1 was similar to the 40% recovery obtained by 
Cawood et al. (1991). Figure 2 presents chromatograms of sample 84 containing >95% pure 
FB, (A) and a water blank (B), analyzed by HPLC-OPA fluorescence. These figures show 
the lack of any OPA derivatizable contaminants in this sample purified by our procedure. 
This same sample was analyzed by Dr. Plattner using HPLC-OPA fluorometry (95.9% FB,) 
and by electrospray-MS (96.8% FB,) (Fig. 3). 
We were unable to obtain pure FB, from solid com, solid rice, or liquid-Myro media 
using Miller's {et al., 1994) silica or Meredith's {et al., 1996) cyano LC procedures. Our 
group found that FB, produced by F. proliferatum strain M5991 from liquid cultures was 
easier to purify than FB, produced on solid com medium. The principal FB produced by F. 
proliferatum strain M5991 is FB, (>90%). We believe that FB, purified from liquid cultures 
of this strain has an advantage over that of other FB producers because of the production of 
high levels of FB, and low levels of other FBs. 
Conclusions 
We have demonstrated an alternate and reproducible method for purification of FB, 
from liquid cultures of F. proliferatum strain M5991. This method could be applied to the 
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purification of FB,, FB,, and FBj (work in progress) since they can be separated from FB, 
during Cg LC. In addition, purification and recovery of FB, were not altered by the addition 
of CHE to the liquid Myro medium. 
Filtered sample of Fusarium proliferatum strain M5991 
liquid culture containing 500 mL of 1000 mg crude FB,/L 
i 
r- > 
XAD-16 Adsorption LC 
^ash with 4 L of 0% ACN, elute with 4 L of 50% ACN, collect 4 L 
i 
r Cg Partition LC 
wash with 250,250, and 150 mL of 0,20, and 25% ACN+0.1% TEA 
elute with 400 mL of 30% ACN+0.1% TFA 
collect elated fractions (10 mL/tube) ^ 
4-
DEAE-Sepharose Ion Exchange LC 
pH adjusted to 6.5 
wash with 100 mL each of 0,100, and 200 mM NH4-OAc:ACN (50:50) 
elute with 100 mL each of 300 and 400 mM NH4-OAC:ACN (50:50) 
collect eluted fractions (100 mL/flask) 
C,g Partition LC 
pH adjusted to 3.3 
wash with 60 mL each of 0,20, and 25% ACN + 0.1% Ac 
elute with 60 mL each of 30 and 35% ACN + 0.1% Ac 
collect eluted fractions (10 mL/tube) 
Figure I. Purification procedure for fiimonisin B, (FB,). 
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Figure 2. HPLC-OPA chromatogram of fumonisin B,. Fumonisin B, containing sample 84 
(4.6 mg fumonisin B,/L) (A) and a water blank (B). 
lOO, 
lOOt 
820 1640 25 00 
Figures. HPLC-MS Chromatogram of fumonisin B,. Analysis of underivatized fiimonisin 
B, in sample 84 analyzed by Dr. R. Plattner using electrospray interface-MS detection 
(Mode: ESI +Q1MS LMR UP LR; Peak: 1000.00 mmu; Masses scanned: 250 - 950 m/z). 
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CHAPTER 5. EXCRETION OF "C-FUMONISIN B„ "C-HYDROLYZED 
FUMONISIN B„ AND "C-FUMONISIN B,-FRUCTOSE BY RATS 
A paper to be submitted to the Journal of Agriculture and Food Chemistry 
William R. Dantzer'-^ Joan Hopper^, Kathy Mullin\ Suzaime Hendrich', and 
Patricia A. Murphy' '' 
Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa 
Abstract 
['''C]-Fumonisin B, (FB,) was produced by Fusarium proliferatum M-5991 in 
modified Myro liquid medium (LM) and purified to >95% purity with a specific activity of 
1.7 mCi/mmole. Nine male and 9 female F344/N rats were dosed by gavage with 0.69 
Hmole ["Cl-FB, or ["C]-HFB, or ["C]-FB,-FRU/kg BW. Urinary excretion of ["C]-HFB, 
by female rats was significantly greater than male rats at 17.3 and 12.8% of the dose, 
respectively. Urinary excretion by male and female rats combined was 4.4 and 0.5% of the 
['•'C]-FB|-FRU and ["CJ-FB, dose, respectively. In a biliary excretion study, 9 Sprague-
Dawley female rats were dosed by gavage with 0.69 ^mole ['•'C]-FB, or ['''C]-HFB, or ['"*€]-
FB,-FRU/kg BW. There was no difference in the biliary excretion of the 3 FB compounds in 
these rats with 1.35% of the dose being excreted in the bile 4 hr after dosing. These data 
' Graduate student. Assistant Professor, and Associate Professor, respectively. Department of 
Food Science and Human Nutrition, Iowa State University. 
• Primary researcher and author. 
^ Iowa State University, College of Veterinary Medicine Laboratory Animal Resources. 
* Author for correspondence. 
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suggested that HFB, was absorbed to a greater extent than FB, in these rats. In a comparison 
of HFB, and FB,, both were equally toxic but, on a dietary basis, HFB, was absorbed to a 
greater extent in rats suggesting that HFB, was less toxic at the cellular level. The 
detoxification of FB, by reaction with fi^ctose was not explained by the absorption of FB,-
FRU which was greater than FB, in rats. 
Introduction 
The fiimonisins (FBs) are a family of mycotoxins including FB,, FB,, FB3, and FB4 
(Gelderblom et al., 1988; Cawood et al., 1991) with FB, being the most predominant. 
Fumonisins are mainly produced by the maize pathogens Fusarium proliferatum and 
Fusarium moniliforme. Fumonisin consumption by horses can cause equine 
leucoencephalomalacia (ELEM) (Kellerman et al., 1990) and by pigs can cause porcine 
pulmonary edema (PPE) (Osweiler et al., 1992; Colvin and Harrison, 1992). Consumption of 
FBs has been associated with other diseases such as embryopathogenicity in chicken (Javed 
et al., 1993), developmental toxicity in hamsters (Floss et al., 1994), and kidney toxicity and 
liver cancer in rats (Gelderblom et al., 1991; Voss et al, 1993). The effects of FBs on 
humans are not known. However, epidemiological studies have suggested a correlation 
between high levels of FBs in com consumed by humans and human esophageal cancer 
(Syndenham et al., 1990; Elheeder et al., 1992; Chu and Li, 1994). Fumonisin B, is a 
probable human class 2B carcinogen (lARC, 1993). 
Fumonisin B, has been labeled using ['"CJ-acetate or ['"CJ-methionine in cultures of 
F. moniliforme or F. proliferatum in liquid medium (LM) (Norred et al., 1993; Blackwell et 
al, 1994; Lebepe-Mazur, 1993). Norred et al. (1993) detected 80% and 2.3% of 1.4 jimole 
['''C]-FB,/kg BW dosed by gavage in the feces and urine of fasted rats, respectively. The 
livers, kidneys, and blood of these rats retained 0.6% of the ["C]-FB,-dose after 96 h. 
Shephard et al. (1992) detected 100% and trace levels of 10.4 (imole ['^C]-FB,/kg BW dosed 
by gavage in the feces and urine of fed rats, respectively after 24 h. Trace levels of the ['''C]-
FB,-dose v^rere detected in the livers, kidneys, and blood of rats. A comparison of Norred's et 
al. (1993) fasted rats to Shephard's et al. (1992) fed rats showed a greater urinary excretion 
in fed rats compared to fasted rats suggesting enhanced absorption in fasted rats. Shephard et 
al. (1994) reported 0.2% of a ['^C]-FB,-dose in the bile of fed rats dosed by gavage with 10.4 
fimole ['•'C]-FB,/kg BW after 24 h. Hopmans et al. (1997) administered 0.69,6.93, or 69.3 
jimoles of FB,/kg BW to fed rats resulting in 7.4, 1.2, and 0.5% of the FB, dose was excreted 
in the urine, respectively. 
Previous attempts to detoxify FB, by ammoniation and dry heat treatments have been 
unsuccessful (Norred et al., 1991; Dupuy et al., 1993). Alkaline hydrolysis of the 
tricarboxylic (TCA) groups of FB, produced hydrolyzed FB, (HFB,) which was found to be 
as toxic as FB, to rats fed a nutritionally adequate diet (Hendrich et al., 1993). However, 
HFB, may be less toxic than FB, because HFB, was absorbed 2-fold more than FB, by rats 
(Hopmans et al., 1997). Detoxification of FB, may occur by formation of the SchifFs base, 
FB,-FRU (Murphy et al., 1995). Lu et al. (1997) reported FB|-FRU did not cause rat hepatic 
cancer promotion. Hopmans et al. (1997) reported that FB,-FRU had a greater urinary 
excretion than FB, in rats. The lack of toxicity of FB,-FRU could not be explained by its 
lower absorption than FB, in rats. Norred et al. (1993) recovered 35% of the ['''C]-dose in 
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tlie feces from fasted rats dosed by iv with 6.2 mnole ['•'C]-FB,/rat after 96 h. Shephard et al. 
(1992) recovered 66% of the [''*C]-dose in the feces from fed rats dosed intraperitoneally with 
10.4 lamole ['''C]-FB,/kg BW after 24 h. In Shephard et al. (1994), 67% of a ['^C]-dose was 
detected in the bile of fed rats dosed intraperitoneally with 10.4 ^mole ['•'C]-FB,/kg BW after 
24 h and 0.2% of a ['''C]-dose was detected in the bile of fed rats dosed by gavage with 0.4 
(imole ['''C]-FB|/kg BW. The biliary excretion of the HFB, and FB,-FRU have not been 
previously investigated. The objective of this study was to compare the urinary, fecal, and 
biliary excretion of 0.69 fimoles of ['''C]-HFB, and ['•'C]-FB,-FRU/kg BW to ['"CJ-FBi/kg 
BW dosed by gavage by rats. 
Materials and Methods 
Reagents were from Fisher Scientific (St. Louis MO) unless otherwise stated. The 
FB| produced from Fusarium cultures is considered class 2B carcinogens (IARC, 1993) and 
caution should be taken during their handling. We assume that HFB, is a potential 
carcinogen and should be treated accordingly. 
Liquid cultures (500 ml) of F. proliferatum strain M5991 were prepared as in Dantzer 
et al. (1996a) and inoculated into Myro liquid medium (LM) which had MgS04 reduced to 
0.5 g/L and contained 1.00% (v/v) com hull extract (modified Myro LM). The inoculum 
culture was incubated for 4 days (d) on a rotary shaker at 220 rpm and 25°C. Aliquots (0.5 
ml) of the F. proliferatum M-5991 inoculum culture were transferred into each of 3 rubber 
stoppered 125 ml Erlenmeyer flasks containing 50 ml of modified Myro LM. Compressed 
air was cleaned by passing through an enclosed 2 L plastic bottle containing air, then bubbled 
through a series of 4 enclosed 2 L plastic bottles containing; IL of 2N KOH, 2N KOH. 
distilled water (dH^O), and 2N H2SO4, respectively, passed through a moisture trap, and 
filtered with a 0.2 inline filter. The purified air was bubbled through the F. proliferatum 
inoculated culture flasks at 0.5 ml/min while the flasks were incubated on a rotary shaker 
(220 rpm) at 20-25°C for 30 d. One ml aliquots were removed from the culture flasks every 7 
d and stored at -20°C until FB analysis. 
Iowa State University (ISU) Environmental Health and Safet>' guidelines for '''C use 
were followed throughout. Glassware was cleaned by soaking in Nochromix laboratory glass 
cleaner (GODAX Laboratories, Inc., Takoma Park, MD) for >15 min. An aliquot containing 
0.5 ml of a 4 d old F. proliferatum M-5991 LM culture was transferred into a rubber 
stoppered 125 ml Erlenmeyer flask. The filtered purified air was bubbled into the flask at 0.5 
ml/min and allowed to exit through Tygon tubing (3.2 or 4.8 mm ID x 6.4 mm OD; formula 
R-3603; Norton Performance Plastics, Akron, OH) to a CO, trap consisting of two rubber 
stoppered 20 x 150 mm test tubes assembled in series each containing 20 ml of 2N KOH. 
The flask was incubated at 220 rpm and 20-25°C on a rotary shaker for 10 d and a 100 |al 
aliquot was removed once for pre-labeling FB, quantification. The ethanol (EtOH) 
containing 56 mCi/mmole of [l,2-'''C]-acetate (American Radiolabeled Chemicals Inc. St. 
Louis, MO, Lot # 960214) was evaporated and the residue was redissolved in milli-Q water 
(MqHjO). Four equal aliquots of 0.25 mCi of [1,2-'''C]-acetate were transferred into the F. 
proliferatum flask after 12, 15, 18, and 21 d to equal a total of 1.00 mCi [l,2-'''C]-acetate. 
Preliminary work indicated EtOH decreased production of FB, and cell density by F. 
proliferatum M-5991. The culture was agitated on a shaker at 220 rpm throughout and 
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harvested 13 d after ['""C] addition. The KOH-'^'CO, trap tubes were replaced every 24 h after 
the initial addition of ['''C] and counted in ScintiVerse BD scintillation fluid for 4 min using a 
Packard liquid scintillation analyzer Model 1900TR (Packard Instrument Co., Downers 
Grove, IL). 
['''C]-Fumonisin B, purification was performed according to the procedure of Dantzer 
et al. (1996b) with a few modifications. Briefly, the 50 ml of ['''C]-FB, containing LM was 
filtered through a Whatman #1 filter (Whatman Laboratory Division, Springfield Mill, 
Maidstone, Kent) followed by 0.8 and 0.45 ^m MSi filters (4.5 cm dia, nylon; Micron 
Separations Inc., Westboro, MA). The ['"'CJ-FB, was fi-actionated on XAD-16, Cg, DEAE-
Sepharose, and C,8 colunms. The XAD-16 column was a 30 x 2 cm glass column with 50 g of 
Amberlite XAD-16 (Sigma Chemical Co., St. Louis MO). The column was washed with 150 
ml of MqHiO and the FB, was eluted with 150 ml of 50% acetonitrile (ACN). All other 
purification procedures were the same as in Dantzer et al. (1996b). After elution of the ['''CJ-FB, 
fi-om the C,g column, the sample was concentrated by rotary evaporation at 45°C, freeze-dried, 
weighed, rehydrated in 50% ACN, and quantified for FB,. Three aliquots, each containing 1.39 
jimole ['•'C]-FB„ were rotary evaporated to dryness at 45°C and used to prepare ['•*C]-FB,, 
['''C]-HFB|, or ['"CJ-FBi-FRU dosing treatments. For preparation of the ['''CJ-FB, treatment, 
an aliquot containing 1.39 ^mole ['"Cl-FB, was rehydrated in 10 ml of MqHjO and stored at 
-20°C until used for animal dosing. For preparation of the ['''C]-HFB, treatment, an aliquot 
containing 1.39 |imole ['"CJ-FB, was rehydrated in 5 ml MqHjO and hydrolyzed in a marble 
capped test tube (12.5 x 1.5 cm) with 1 ml of 2N KOH for 2 h in boiling HjO. The pH of the 
HFB, solution was adjusted to <3 using 12N HCl and loaded onto a PrepSep P479-C,8 
extraction column (Fisher Scientific). The column was washed with 20 ml of MqH20 and 
the HFB| was eluted with 10 ml MeOH (Hopmans et al., 1997). The MeOH was removed 
from the ['''C]-HFB, by rotary evaporation at 45''C. The ['"'Cj-MFB, was rehydrated in 10 ml 
of MqHjO and stored at -20°C until used for animal dosing. For preparation of the ['''CJ-FB,-
FRU treatment, an aliquot containing 1.39 [imole ['''C]-FB, was rehydrated in 10 ml of 0.05 M 
K2HPO4 at pH 7 containing 0.1 M D-fructose and heated at 80°C for 48 h (Hopmans et al., 
1997). The volume of the heated FB,-FRU solution was adjusted to 10 ml with MqH,0 and 
stored at -20°C until used for animal dosing. 
The concentrations of ['''C]-FB, and -HFB, were estimated by HPLC o-
pthaldialdehyde (OPA) fluorometry using a Turner fluorometer (Coming 7-60 primary filter 
and Wratten 2a secondary filter, 15 fA flow cell) (Dantzer et al., 1996b). Purity of ['''CJ-FB, 
was determined by comparing the HPLC-OPA quantified amounts to the freeze-dried 
weights of the purified ['"'Cl-FB, sample. A purified sample of FB, was used to generate a 
FB, standard curve (Dantzer et al., 1996b). The ['''C]-HFB| sample was quantified for HFB, 
by comparing the HPLC-OPA quantified amounts to a HFB, standard curve. The HFB, 
standard was generated in our lab according to the procedure of Hopmans et al. (1997). The 
['''C]-FB,-FRU sample was analyzed for residual free ['"CJ-FB, by HPLC-OPA. 
The animal protocol and use was approved by the ISU Animal Care Committee. 
Eighteen Fisher 344/NHsd rats, 9 male and 9 female at 7-8 and 9-10 wk of age, respectively, 
with a BW range of 135-160 g were used for the urine and fecal excretion study. All rats 
were housed individually and fed AESI 93M diet (Reeves et al., 1993) and tap water ad lib for 
1 wk with a 12 h light cycle. Following the 1 wk acclimation period and at the end of a light 
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cycle. 3 male and 3 female rats were administered 0.69 jamole ['^C]-FB,. ['•'C]-HFB,. or 
["'C]-FB,-FRU/kg BW by gavage. The rats were housed individually in metabolic cages and 
fecal and urine samples were collected at 12 h intervals. At 84 h, the rats were sacrificed by 
CO, asphyxiation, blood was drawn by heart puncture, and hearts, livers, lungs, kidneys, and 
brains were removed for ['''C] analysis. 
Nine female 15 wk old Sprague-Dawley rats with a BW range of 240-270 g were used 
for the biliary excretion study. All rats were housed individually and fed AIN 93 M diet 
(Reeves et al., 1993) and tap water ad lib for 1 wk with a 12 h light cycle. Following the 1 
wk acclimation period and at the end of a light cycle, the rats were anesthetized with 5 ml of 
urethane (Sigma) solution (0.25 g urethane/ml sterile H20)/kg BW intraperitoneally and their 
bile ducts were surgically cannulated with a 24 cm long piece of silicone rubber tubing (0.3 
mm ID X 0.6 mm OD; BrainTree Scientific Inc., Braintree, MA). Following caimulation, the 
tubing was fed through a large bore needle placed in the right side of the abdomen of each 
rat. After passing the tubing through the needle, the needle was withdrawn and the abdomen 
surgically closed. Immediately after caimulation, 3 rats were gavaged with 0.69 |imole ['''C]-
FB|, ['''C]-HFB,, or ['''C]-FB|-FRU/kg BW and placed on their left sides on a hot water 
heating pad set at medium power. Bile was collected into 1.5 ml graduated micro centrifuge 
tubes every 30 min until the rats expired or at sacrifice 9.5 h after dosing. Livers, kidneys, 
stomach wash, stomach tissue, and the T", 2"'*, and 3"* sections (I, II, and III) of the intestines 
were collected after the rats expired or at sacrifice 9.5 h after dosing. All samples were 
stored at -20°C until analyzed. 
Fecal samples, oven-dried at 60°C overnight, and intestinal tissues, frozen with liquid 
Nj, were ground in a porcelain mortar and pestle. Ground fecal and intestinal tissues, 
stomach tissues, stomach washes, kidneys, livers, lungs, blood, and brains were separately 
blended with a tissue homogenizer (Model TR-10, Tekmar Co., Cincinnati. OH) at 60% 
power for 0.5 to 1 min in 5 ml MqHiO, brought to a known volume (10 to 35 ml) with 
MqHiO, and quantified for ['"^C] on a scintillation analyzer. Quenching of ['""C] was 
evaluated by measuring ['''C] in 1 ml fecal, urine, liver, kidney, or dH^O solutions or 0.5 ml 
of intestinal tissue, stomach wash, stomach tissues, or dH,0, with and without 0.1 ml ACN 
containing 18,400 dpms from 0.02 jamoles of ['"CJ-FB,. The quenching % was used to 
correct data from each sample. 
The statistical treatment of the urine and fecal excretion of the FB forms, [''*C]-FB„ 
['''C]-HFB„ and ['''C]-FB,-FRU, were a completely randomized design of 18 rats. Three 
male and 3 female rats were randomly assigned to each treatment. The statistical protocol of 
the biliary excretion of the FB forms, ['''C]-FB„ ['''CJ-HFB,, and ['''C]-FB,-FRU, were a 
completely randomized design of 9 rats. Three female rats were randomly assigned to each 
treatment. Differences among treatment means were assessed by a students t-statistic with p 
< 0.05 as level of significance using the SAS package (V 6.03, 1995, Cary, NC). 
Results and Discussion 
Log-phase production of FB, by F. proliferatum culture occurred during 10-14 d 
followed by a linear increase in FB, through 31 d yielding 1200 famoles FB,/L (Fig. 1). 
There was an average production of 0.18 |iCi ""COj/h within the first 24 h period after each 
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addition of 250 jaCi ['•'C]-acetate (Fig. 1). The production of'"'CO, decreased to undetectable 
levels 3 d after addition of the ['•'C]-acetate. The culture was harvested at 24 d. The FB, was 
purified to >95% purity with a yield of 24 jimoles and a specific activity of 1.7 mCi/mmole. 
['''C]-Fumonisin B, measurement in biological material allows for improved ability to 
monitor FB, compared to HPLC-fluorescence methods. However, quantifying for [''*C]-FB, 
will not reveal any information on metabolic modification of FB or its related forms. 
The doses for the urine and fecal excretion study contained 0.14 |amole of ['^CJ-FB,. 
['•'CJ-HFB,, or ['''C]-FB,-FRU/ml MqH^O with specific activities of 1.7, 1.2, and 1.8 
mCi/mmole, respectively. The lower specific activity of [""CJ-HFE, suggested that some of 
the TCA groups had been labeled during ['"CJ-FB, production and were removed by 
hydrolysis to produce ['''C]-HFB,. 
Dosing of rats during the urine and fecal excretion study occurred at the end of a light 
cycle suggesting the animals were not actively feeding for 12 h prior to dosing. The 
quenching analysis indicated that blood had the highest average quenching at 86% followed 
by liver at 28% of the added ['''CJ-FB,. All other constituents had little quenching (Table I). 
The data on time course of excretion of ['""C] in urine of male and female rats, for each FB 
form, were combined because they were not significantly different except for urinary 
excretion of HFB, during 0-12 h after dosing (Fig. 2). There was 15.0, 4.4, and 0.6% of the 
['"Cj-dose excreted in the urine dosed with 0.69 jimole ['"CJ-HFB,, ['"'CJ-FB,-FRU, and 
['''CJ-FB,/kg BW, respectively (Table 2). The average half-life of the FB compounds 
retained by these rats was 10 h. The urinary excretion of ['''CJ-HFB, persisted up to 60 h 
after dosing with a maximum of ['"'CJ-HFB, being excreted between 12 and 24 h. The 
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excretion of ['"'Cj-HFB, resembled a one-compartment model of elimination. The 
elimination of ['•'C]-FB,-FRU persisted in the urine of these rats up to 24 h after dosing (Fig. 
2). The urinary excretion of ['•'C]-FB,-FRU persisted up to 24 h with a maximum of ['''C]-
FB|-FRU being excreted between 0 and 12 h. The excretion of ['•'C]-FB,-FRU in these rats 
resembled a one-compartment model of elimination. There were only trace amounts of ['^C]-
FB| excreted in the urine of these rats and most of that was excreted in the first 12 h after 
dosing (Fig. 3). Over 25-fold more ['''CJ-HFB, was excreted in the urine of male and female 
rats than ['^C]-FB, suggesting that HFB, had a greater bioavailability. The greater 
bioavailability of HFB, than FB, with comparable toxicity (Hendrich et aL, 1993) suggested 
that FB| was more toxic than HFB, at the cellular level to rats. Total excretion of ['•'C]-FB,-
FRU in the urine of male and female rats was 8-fold greater than FB, suggesting that ['"'C]-
FB,-FRU had a greater bioavailability than FB, in these rats (Table 2). Fumonisin B,-FRU 
was a detoxified form of FB, in rats (Lu et al.^ 1997). However, its detoxification 
mechanism was not due to reduced absorption since its bioavailability was greater than that 
of FB, in rats. Our total urinary excretion of 0.69 ^moles HFB, and FB|-FRU/kg BW 
compared to 0.69 [imoles FB,/kg BW by male and female Fisher rats after 84 h were similar 
to the urinary excretion by male Fisher rats observed by Hopmans et al. (1997) after 96 h. 
Both studies reported the same total percent urinary excretion of HFB, and relative 
absorptions of tffB, and FB,-FRU compared to FB,. However, in the study by Hopmans et 
al. (1997) rats dosed with 0.69 jimoles of FB,-FRU or FB,/kg BW excreted 2-fold more 
percent total dose of FB,-FRU and 14-fold more percent total dose of FB, in the urine than 
our rats. Hopmans et al. (1997) correlated FB, and FB,-FRU to the amount of OPA-HFB, in 
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the hydrolyzed rat urine. Hydrolysis of urine was performed to free up the amine group on 
the FB, molecule for OP A binding. In our study, FB, and FB,-FRU were correlated to the 
amount of ['"'C] detected in the rat urine. The differences in these two studies may reflect the 
differences in analysis. Norred et al. (1993) found 2-3% of a gavaged dose of 1.4 [imole 
['^C]-FB|/kg BW was excreted in the urine of fasted Sprague-Dawley rats after 96 h 
suggesting that their fasted rats had a greater absorption of FB, than our fed rats. This 
apparent higher absorption by Norred's rats compared to our rats may have been attributed to 
differences in strain of rat or, more likely, in absorption of FBs between fasted and fed rats. 
In fed rats, solids may tie up the FBs and make them less available for GI tract absorption. 
The data on the time course of fecal excretion of ['"*0] in male and female rats, dosed 
with the same compound, were combined because they were not significantly different 
according to gender (Fig. 3). The pattern of fecal excretion of ['''CJ-FB,, ['"'Cj-HFB,, and 
['''C]-FB,-FRU followed a normal excretion of a compound through the fecal route (Casarett 
and Doull, 1991) with maximum excretion of ['""C] from the 3 compounds to be recovered in 
the feces between 12 and 24 h. After 60 h, only trace amounts of ['•*€] were recovered in the 
feces from these rats. Total fecal excretion was not significantly different between 
compoimds or gender and averaged 90% recovery of total dose after 84 h (Table 2). 
The total ['''C] recovered from the hearts, brains, livers, blood, kidneys, or lungs of 
rats dosed with 0.69 ^mole ["C]-FB„ ["C]-HFB„ or ["C]-FB,-FRU/kg BW was not 
significantly different from 0 for all rats indicating that accumulation of these compounds did 
not occur after 84 h (Fig. 4, Table 2). 
103 
In the biliary excretion study, Sprague-Dawley rats were used to obtain rats big 
enough for the canulation procedure. The same treatments were used for the biliary excretion 
study as in the urinary excretion study. However, to obtain proper volumes, the 0.14 [imole 
[''*C]-HFB, and ['•'C]-FB,-FRU/ml MqH^O treatments were diluted with unlabeled 0.14 
lamole HFB, or FB,-FRU/ml MqHjO which resulted in specific activities of 0.7 and 1.0 
mCi/mmole, respectively. In the bile excretion experiment, all 9 of the cannulated female 
rats survived for 4 h after dosing. Biliary excretion of 0.69 ^imole ['""Cj-FB,, ['''CJ-HFB,, or 
['"CJ-FBi-FRU/kg BW by female rats were not significantly different with 1.35% of the total 
['•"CJ-dose excreted 4 h after dosing (Table 3). Biliary excretion of the 3 FB compounds 
increased fi-om 0 to 0.5% of the total dose per 0.5 h interval within 2 h after dosing (Fig. 5). 
The 3 forms of FB continued to be excreted in the bile by the rats up to 9.5 h after dosing 
(Fig. 6). The large error bars seen in the biliary excretion data may suggest the presence of 
fluorescent compounds that have been previously observed in rat bile (Hicks et al., 1984). 
Only 2 rats from the ['"CJ-FB, dose and 1 rat from the ["'Cj-HFB, and ['"CJ-FBi-FRU doses 
survived for 9.5 h. Shephard et al. (1994) recovered almost 7-fold less at 0.2% of the total 
['•'CJ-dose in the bile of cannulated rats gavaged with ['^C]-FB, compared to our rats. 
However, Shephard's et al. (1994) rats were not under anesthesia during gavaging of [''*C]-
FB, or bile collection. A large portion of the ["''CJ-dose of the 3 forms of FB, were recovered 
in the stomach contents of our rats (41% of the total dose) indicating that only about 1/2 of 
the dosed-FB compounds left the stomachs of these rats (Table 4). This could possibly be 
because these rats were under anesthesia throughout the duration of the experiment which 
may have resulted in a slower rate of GI tract absorption compared to Shephard's et al. 
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(1994) rats. The pooled stomach tissues, intestines, and bile samples from the rats contained 
10 ± 8, 8 ± 9 and 3 ±4% of the total dose, respectively. Kidneys and livers contained less 
than 1% of the ['''C]-dose. Total recovery of the ['"'CJ-doses from these rats of the bile 
excretion study averaged 63 ± 17%. 
Conclusions 
The 25-fold greater absorption of ['"'Cj-HFB, than that of ['"'CJ-FB, in male and 
female Fisher rats suggested that, once in circulation, HFB, was less toxic than FB,, on a 
molar basis, because both have been shown to be equally toxic on a dietary basis to rats 
(Hendrich et al., 1993). Detoxification of FB, by formation of FB,-FRU was not the result of 
decreased absorption since ['•'C]-FB,-FRU was absorbed 8-fold more than ['"CJ-FB, by these 
rats. These data compliment and extend the findings of Hopmans et al. (1997) suggesting 
that HFB, or FB,-FRU were absorbed more than FB, by the GI tract of rats. In addition, 
there were no differences in biliary excretion of ['''C]-FB,, ['"CJ-HFB,, or ['''C]-FB,-FRU by 
these rats. This finding suggests that the observed decrease in urinary excretion of FB, 
compared with HFB, or FB,-FRU was due to a decreased absorption of FB, relative to HFB, 
or FB,-FRU by the Gl tract of these rats. 
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Table 1. Detectability of ['""C] in biological samples spiked with ['"'CJ-FB,. 
PERCENT 
AVE OF DOSE 
SAMPLE DPM DETECTABLE 
Urine 17,902 97 
Feces 22,662 123 
Lung 17,231 94 
Heart 17,521 95 
Brain 18,188 99 
Liver 13,358 72 
Blood 2,536 14 
Kidney 16,897 92 
Bile 18,763 102 
Intestine 17,708 96 
Samples were spiked with 100 ml of acetonitrile containing 
18,000 dpms fi'om 0.02 mmoles of ['^C]-FB,. 
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Fig. 1. Production of'''CO, (piCi/h) and FB, (|j.moles/L) by Fusarium proliferatum M-5991. 
Bar plot represents production of '''CO, (fiCi/h) by F. proliferatum M-5991 in 50 ml of 
modified Myro liquid medium (LM) spiked with 0.25 mCi ["*C]-acetate after 12, 15. 18. and 
21 d of incubation. Line plot represents FB, (|imoles/L) produced by F. proliferatum M-
5991 in 50 ml of modified Myro LM. Error bars represent ± 1 standard deviation of 3 
replicates. 
-J 
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Fig. 2. Percent excretion in urine of total ['"CJ-dose per 12-h interval by groups of 3 male 
and 3 female rats dosed with 0.69 iimole ['"Cj-FB, or ['"CJ-HFB, or ["'C]-FB,-FRU/kg BW. 
Error bars represent ± 1 standard deviation (n=6). * There was a significant difference 
between male and female rats for treatment-time interval. Data within a time interval with 
different superscripts are statistically different (p<0.05). 
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Table 2. Percent recovery of total '""C of 0.69 jamoles of ['•'C]-FB, or ['''C]-HFB, or ['""C]-
FB,-FRU/kg BW in male and female rats after 84 h. 
PERCENT TOTAL DOSE 
TOTAL 
—URINE— —FECES— —TISSUES— -RECOVERY-
DOSE MALE FEMALE MALE FEMALE MALE FEMALE MALE FEMALE 
['^CI-FB, 0.44'* 0.72'* 84.98 95.49 0.28 2.72 85.7 98.9 
['••CI-HFB, 17.30° 86.81 91.42 0.14 1.31 99.8 110.0 
["C|-FB,-FRU 4.18° 4.59° 86.20 97.00 0.19 0.42 90.6 102.0 
Different superscripts are significantly different (p<0.05). MSEunnj = 2; = 89; 
MSE,issues = 2; = 81. Data within feces, tissues, or total recovery are not 
significantly different (p<0.05). 
• FBI gHFBI nFBl-FRU 
6 18 30 42 54 66 78 
TIME(lir) 
Fig. 3. Percent excretion in feces of total ['''C]-dose per 12-h interval by groups of 3 male and 
3 female rats dosed with 0.69 |imole ['''C]-FB, or ['"'Cj-HFB, or ['''C]-FBi-FRU/kg BW. 
Error bars represent ± 1 standard deviation (n=6). Data within each time interval were not 
significantly different (p<0.05). 
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Fig. 4. Percent tissue accumulation of total '''C dose by groups of 3 male and 3 female rats 
(n=6) dosed with 0.69 ^imole ["C]-FB, or ["C]-HFB, or ["C]-FB,-FRU/kg BW. Error bars 
represent ± 1 standard deviation. Data within each tissue group were not significantly 
different (p<0.05). 
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Fig. 5. Percent biliary excretion of total dose per 0.5 hour interval by groups of 3 female 
rats dosed with 0.69 ^mole ["C]-FB, or ["C]-HFB, or ["C]-FB,-FRU/kg BW. Error bars 
represent ± 1 standard deviation (n=3). 
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TIME(hr) 
Fig. 6. Percent biliary excretion of total '""C dose per 0.5 hour interval by female rats dosed 
with 0.69 lamole ["C]-FB, or ["C]-HFB, or ['^C]-FB,-FRU/kg BW. Bars with error bars 
represent means ± range (n=2). Bars without error bars represent n=l. 
Table 3. Biliar>' excretion of ['''C]-dose by female rats gavaged with 0.69 jimole ['^C]-FB, or 
["C]-HFB, or [''C]-FB,-FRU/kg BW 4 hours after dosing. 
PERCHVr BUJARY EXCREHON 
OF ('^ q-DOSE AFTER 4 HOURS 
STANDARD 
DOSE AVERAGE DEVIATION 
fbJ ils Hi 
HFB, 1.71 1.99 
FB,-FRU 0.80 0.82 
n=3 
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Table 4. Percent of total ['"'C] dose (%) recovered in constituents from female Sprague-
Dawley rats dosed with 0.69 (imoles of ['•'C]-FB,, -HFB,, or -FB,-FRU and the duration (hr) 
until expiration of each rat after dosing. 
PERCENT OF TOTAL ['^Cl-DOSE (%) 
FB, HFB, FB,-FRU 
RAT RAT RAT 
PARAMETER 1 2 3 I 2 3 1 2 3 
BILE 11.1 0.1 0.2 6.6 0.2 I . l  2.9 0.4 0.3 
KIDNEYS 0.9 0.0 0.1 0.1 0.0 0.8 0.4 0.2 0.0 
LIVER 1.4 0.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 
STOMACH WASH 17.9 65.7 34.1 21.4 87.6 16.2 34.4 46.2 42.4 
STOMACH TISSUE 16.8 3.7 7.6 7.0 7.3 4.1 29.5 4.4 7.0 
INT I TISSUE 2.4 0.0 1.8 14.5 0.0 0.5 5.1 15.8 1.8 
INT II TISSUE 0.0 0.1 0.0 2.5 0.0 4.9 0.0 0.0 0.0 
INT III TISSUE 0.0 10.2 0.0 0.6 0.4 22.8 0.0 0.2 0.0 
TOTAL 50.0 80.0 45.0 53.0 96.0 51.0 72.0 67.0 52.0 
DURATION (hr) 9.0 9.0 4.0 9.0 7.0 4.0 9.0 4.5 3.5 
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CHAPTER 6. GENERAL CONCLUSIONS 
A. Summary 
The structure of fumonisin B, (FB,) suggests that it is a symmetrical molecule that 
may be able to fold into different configurations and is water soluble. From a toxicologist's 
standpoint, the active groups on a FB molecule include the tricarboxylic acid groups, primary 
amine group, and a C20 backbone with 1 to 3 hydroxyl groups and 2 methyl groups attached. 
Fumonisin B, has been shown to be only slightly absorbed by the gastrointestinal (Gl)-tract 
of animals. However, it is capable of causing major health problems such as 
leucoencephalomalacia, pulmonary edema, liver cancer, or kidney disease in different 
animals (Kellerman et al., 1991; Osweiler et al., 1992; Gelderblom et al., 1991; Voss et. al., 
1993). In studies described in this dissertation, less than 2% of the ['•'C]-FB,-dose was 
absorbed by the GI tract of rats. Of the 2% absorbed dose, it is estimated that 25% was 
excreted in the urine and 75% was excreted in the bile. Altering the form of ['''CJ-FB, to 
['•'C]-hydrolyzed FB, (['''C]-HFB,) or [''*C]-FB,-fructose (['^C]-FB,-FRU) resulted in an 
increased absorption by rats but not in an increased biliary excretion. The ['"'CJ-HFB, form 
may be found in foods such as masa and tortilla flour and was absorbed 30-fold more in the 
GI tract of rats than was ['''C]-FB,. Based on these data and their similar dietary toxicity to 
rats (Hendrich et al., 1993), dietary HFB, may be less toxic than dietary FB, on a cellular 
basis. Another form of ['"CJ-FB, studied here was ['''C]-FB,-FRU, which can be formed by 
heating ['"CJ-FB, with fructose at pH 7. This form was found not to be a cancer promotor 
when fed to rats (Lu et al., 1977). The mode of detoxification of FB,-FRU could have been a 
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decreased absorption by the GI tract of rats. However. Hopmans et al. (1997) reported FB,-
FRU was absorbed more by the GI tract of in rats than was FB,. The decreased toxicity' of 
FB,-FRU compared with FB, was not based on absorption. In this study, ['•'C]-FB,-FRU was 
absorbed 10-fold more than ['"Cj-FB, by rats, confirming the findings of Hopmans et al. 
(1997). If FB,-FRU can be shown not to cause some of the other animal toxicities such as 
ELEM and PPE, then the process of forming FB,-FRU from FB, could be used to treat 
animal feeds that contain FBs. 
These ['"CJ-FB,, [''*C]-HFB,, and [''*C]-FB,-FRU animal experiments required 
production and purification of ['"Cl-FB,. This required optimization of production, 
purification, and radiolabeling of FB,. The production of FB, was optimized by incubating a 
FB,-producing fungi, Fusarium proliferatum M-5991, in a modified Myro liquid medium 
(LM). The modification of the Myro LM included the addition of 1% (v/v) com hull extract 
(CHE) which enhanced the overall growth characteristics of the fungi resulting in a 3-fold 
increase in the production of FB,. The production of FB, in a large scale 12 L fermentation 
vessel was carried out in a serial batch fermentation in which the cell mass was retained from 
batch to batch. The serial batch fermentation demonstrated that the production of FBs could 
be scaled up and optimized to increase the production of FB, by F. proliferatum. This 
procedure also produced FB, in less time than shaker flasks because the vessel did not require 
cleaning after each fermentation batch. Possibly, the serial batch fermentation could have 
been improved. In this experiment, the CHE was only added to the first batch because 
purification of FB, produced from LM enhanced with CHE was not investigated. However, 
no purification problems were observed when the CHE was used in the production medium. 
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The basic chromatography method existed prior to this study but required major optimization 
and the addition of an anion exchange column. Radiolabeling of FB, with ['^C] included the 
addition of 1 mCi ['''C]-acetate to a 12 d old culture of F. proliferatum M-5991 in 50 ml of 
LM spread out over 10 d and resulted in the production of radiolabeled FB, with a specific 
activity of 1.7 mCi/mmole. This specific activity could be increased by adding all of the 
['•'C]-acetate at one time which would decrease the amount of non labeled FB, obtained after 
harvesting. However, due to the low recovery of FB, from the purification procedure, a 
greater loss of the ['""CJ-FB, may have occurred. 
B. Recommendations for Future Research 
This study answered some questions concerning the absorption of 3 forms of FB, in 
rats. However, the absorption of similar forms of FB,, FBj, and FB^ need to be investigated. 
Some Fusarium strains have been shown to produce FB,, FBj, and FB4 preferentially over 
that of FB,. What are the effects that these other FBs and their various forms have on 
animals? Can they be detoxified? Can the detoxified FB,-FRU, which is absorbed more than 
FB,, cause ELEM in horses? 
There is strong evidence suggesting that FBs are toxic, exist in human and animal 
foods, and pose a risk to the health of humans and animals if consumed. However, the levels 
of FBs and the forms of FBs found in foods have not been regulated. Determining the safe 
levels of these compounds in foods needs to be completed. This would also require enhanced 
improvements in the detection of FBs from foods. The ELISA methods offer the ability to 
screen large numbers of samples at one time. However, ELISA methods are not as accurate 
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in quantifying levels of FBs in food systems as are the conventional HPLC-fluorometric 
methods. In summary, other forms of these mycotoxins should be investigated for their 
toxicity, acceptable levels in foods need to be determined, and quick, accurate methods for 
detection of FBs need to be developed. 
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